MIRA INFORM REPORT

 

 

Report Date :

08.08.2013

 

IDENTIFICATION DETAILS

 

Name :

TOYOBO CO LTD

 

 

Registered Office :

Toyobo Bldg., 2-2-8, Dojimahama, Kita-ku, Osaka-Shi, 530-8230

 

 

Country :

Japan

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

26.06.1914

 

 

Legal Form :

Public Parent

 

 

Line of Business :

Manufacturing company that operates in six business segments.

 

 

No. of Employees :

10,566

 

RATING & COMMENTS

 

MIRA’s Rating :

A

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit:

USD 73.35 Millions

Status :

Good

Payment Behaviour :

Regular

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March, 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Japan

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

japan - ECONOMIC OVERVIEW

 

In the years following World War II, government-industry cooperation, a strong work ethic, mastery of high technology, and a comparatively small defense allocation (1% of GDP) helped Japan develop a technologically advanced economy. Two notable characteristics of the post-war economy were the close interlocking structures of manufacturers, suppliers, and distributors, known as keiretsu, and the guarantee of lifetime employment for a substantial portion of the urban labor force. Both features are now eroding under the dual pressures of global competition and domestic demographic change. Japan's industrial sector is heavily dependent on imported raw materials and fuels. A small agricultural sector is highly subsidized and protected, with crop yields among the highest in the world. While self-sufficient in rice production, Japan imports about 60% of its food on a caloric basis. For three decades, overall real economic growth had been spectacular - a 10% average in the 1960s, a 5% average in the 1970s, and a 4% average in the 1980s. Growth slowed markedly in the 1990s, averaging just 1.7%, largely because of the after effects of inefficient investment and an asset price bubble in the late 1980s that required a protracted period of time for firms to reduce excess debt, capital, and labor. Modest economic growth continued after 2000, but the economy has fallen into recession three times since 2008. A sharp downturn in business investment and global demand for Japan's exports in late 2008 pushed Japan into recession. Government stimulus spending helped the economy recover in late 2009 and 2010, but the economy contracted again in 2011 as the massive 9.0 magnitude earthquake and the ensuing tsunami in March disrupted manufacturing. The economy has largely recovered in the two years since the disaster, but reconstruction in the Tohoku region has been uneven. Newly-elected Prime Minister Shinzo ABE has declared the economy his government's top priority; he has pledged to reconsider his predecessor's plan to permanently close nuclear power plants and is pursuing an economic revitalization agenda of fiscal stimulus and regulatory reform and has said he will press the Bank of Japan to loosen monetary policy. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, Japan in 2012 stood as the fourth-largest economy in the world after second-place China, which surpassed Japan in 2001, and third-place India, which edged out Japan in 2012. The new government will continue a longstanding debate on restructuring the economy and reining in Japan's huge government debt, which exceeds 200% of GDP. Persistent deflation, reliance on exports to drive growth, and an aging and shrinking population are other major long-term challenges for the economy.

 

Source : CIA

 


Company name and address

 

TOYOBO CO LTD

                                                                                                                                                           

 

Toyobo Bldg., 2-2-8, Dojimahama, Kita-ku

Osaka-Shi, 530-8230

Japan

 

 

Tel:

81-6-63483111

Fax:

81 (6) 6348-3206

 

www.toyobo-global.com

 

Employees:

10,566

Company Type:

Public Parent

Corporate Family:

33 Companies

Traded:

Tokyo Stock Exchange:

3101

Incorporation Date:

26-Jun-1914

Auditor:

KPMG AZSA LLC

Financials in:

USD (In Millions)

Fiscal Year End:

31-Mar-2013

Reporting Currency:

Japanese Yen

Annual Sales:

4,085.9  1

Net Income:

92.1

Total Assets:

4,755.6  2

Market Value:

1,452.4

 

(19-Jul-2013)

                                         

 

Business Description          

 

 

TOYOBO CO., LTD. is a Japan-based manufacturing company that operates in six business segments. The Film and Functional Plastic segment offers packaging films, industrial films, industrial adhesives, engineering plastic and optical functional materials. The Industrial Material segment offers textile materials for automobile uses, super fibers, functional filters and non-woven cloth. The Life Science segment offers biotechnology products, such as enzymes for diagnostic drugs, as well as pharmaceuticals, medical films, medical devices and aquatic films. The Clothing Textile segment offers functional clothing, apparel products, clothing textiles and clothing fibers. The Real Estate segment is involved in the sale, leasing and management of real estate properties. The Others segment is engaged in the design and construction of buildings and machines, the sale of machines, as well as the provision of financial, information, logistics and linen supply services, among others. For the fiscal year ended 31 March 2013, Toyobo Co Ltd revenues decreased 3% to Y339.01B. Net income increased 67% to Y7.64B. Revenues reflect Textile segment decrease of 10% to Y79.21B, Life Science segment decrease of 7% to Y24.84B, Film and Resin segment decrease of 1% to Y137.39B. Net income reflects Real Estate segment income increase of 24% to Y1.68B, Eliminations and Corporate segment loss decrease of 5% to Y3.13B.

 

 

 

Industry

 

Industry

Rubber and Plastic Product Manufacturing

ANZSIC 2006:

1911 - Polymer Film and Sheet Packaging Material Manufacturing

ISIC Rev 4:

2220 - Manufacture of plastics products

NACE Rev 2:

2221 - Manufacture of plastic plates, sheets, tubes and profiles

NAICS 2012:

326113 - Unlaminated Plastics Film and Sheet (except Packaging) Manufacturing

UK SIC 2007:

2221 - Manufacture of plastic plates, sheets, tubes and profiles

US SIC 1987:

3081 - Unsupported Plastics Film and Sheet

 

 

 

Key Executives

 

Name

Title

Ryuzo Sakamoto

President, Executive President, Representative Director

Yoshikazu Akasaka

Director of Tokyo General Affairs

Yukihiro Sogabe

Corporate Executive Officer

Hiroshi Imanaka

Corporate Auditor

Kazumasa Koyama

Managing Executive Officer, Chief Director of Functional Material Business, Director

 

 

Significant Developments

 

Topic

#*

Most Recent Headline

Date

Divestitures

1

Fujibo Holdings Inc's Subsidiary to Take Over Plant from Toyobo Co., Ltd.

15-Oct-2012

General Reorganization

1

Toyobo Co Ltd to Withdraw from Polyester Tire Cord Business- Response

12-May-2013

Equity Investments

1

Japan Wool Textile Co Ltd to Acquire Shares in ASHIMORI INDUSTRY CO LTD from Toyobo Co Ltd

10-Apr-2013

Dividends

1

Toyobo Co Ltd to Issue Year-end Dividend for FY 2013

24-May-2013

Debt Ratings

1

R&I Affirms Toyobo Co Ltd's Rating at "BBB+"; Rating Outlook Stable

4-Dec-2012

 

* number of significant developments within the last 12 months

 

 

News

 

Title

Date

TOYOBO CO LTD : Consolidated Financial Report for the First Quarter ended June 30, 2013
4 Traders (174 Words)

5-Aug-2013

Tokyo Most Actives
Nikkei English News (590 Words)

5-Aug-2013

Tokyo Stock Exchange: closing price list -9-
Japan Economic Newswire (234 Words)

5-Aug-2013

Toyobo Surges On 500% Net Profit Rise
Nikkei English News (61 Words)

5-Aug-2013

Toyobo Expects This FY Group Net Profit Y9.50B
Nikkei English News (43 Words)

5-Aug-2013

Toyobo 1Q Grp Net Pft Y2.96B Vs Y492.00M Pft Yr Earlier
Nikkei English News (57 Words)

5-Aug-2013

 

 

Financial Summary

 

As of 31-Mar-2013

Key Ratios

Company

Industry

Current Ratio (MRQ)

1.12

2.22

Quick Ratio (MRQ)

0.69

1.09

Debt to Equity (MRQ)

1.13

1.83

Sales 5 Year Growth

-4.71

-1.82

Net Profit Margin (TTM) %

2.47

1.34

Return on Assets (TTM) %

1.89

1.80

Return on Equity (TTM) %

5.69

6.70

 

 

Stock Snapshot

 

Traded: Tokyo Stock Exchange: 3101

 

As of 19-Jul-2013

   Financials in: JPY

Recent Price

164.00

 

EPS

11.37

52 Week High

208.00

 

Price/Sales

0.43

52 Week Low

80.00

 

Dividend Rate

3.50

Avg. Volume (mil)

6.65

 

Price/Earnings

18.58

Market Value (mil)

146,040.00

 

Price/Book

1.06

 

 

 

Beta

0.98

 

Price % Change

Rel S&P 500%

4 Week

12.33%

1.90%

13 Week

0.61%

-6.47%

52 Week

59.22%

-1.85%

Year to Date

33.33%

-5.41%

 

1 - Profit & Loss Item Exchange Rate: USD 1 = JPY 82.97047
2 - Balance Sheet Item Exchange Rate: USD 1 = JPY 94.08855

 

 

Corporate Overview

 

Location
Toyobo Bldg., 2-2-8, Dojimahama, Kita-ku
Osaka-Shi, 530-8230
Japan

 

Tel:

81-6-63483111

Fax:

81 (6) 6348-3206

 

www.toyobo-global.com

Quote Symbol - Exchange

3101 - Tokyo Stock Exchange

Sales JPY(mil):

339,009.0

Assets JPY(mil):

447,445.0

Employees:

10,566

Fiscal Year End:

31-Mar-2013

 

Industry:

Fabricated Plastic and Rubber

Incorporation Date:

26-Jun-1914

Company Type:

Public Parent

Quoted Status:

Quoted

 

President, Executive President, Representative Director:

Ryuzo Sakamoto

 

Industry Codes

 

ANZSIC 2006 Codes:

1911

-

Polymer Film and Sheet Packaging Material Manufacturing

1351

-

Clothing Manufacturing

1841

-

Human Pharmaceutical and Medicinal Product Manufacturing

1915

-

Adhesive Manufacturing

1821

-

Synthetic Resin and Synthetic Rubber Manufacturing

1312

-

Natural Textile Manufacturing

3020

-

Non-Residential Building Construction

1334

-

Textile Finishing and Other Textile Product Manufacturing

6712

-

Non-Residential Property Operators

 

ISIC Rev 4 Codes:

2220

-

Manufacture of plastics products

1399

-

Manufacture of other textiles n.e.c.

6810

-

Real estate activities with own or leased property

2100

-

Manufacture of pharmaceuticals, medicinal chemical and botanical products

1410

-

Manufacture of wearing apparel, except fur apparel

2013

-

Manufacture of plastics and synthetic rubber in primary forms

1312

-

Weaving of textiles

4100

-

Construction of buildings

2029

-

Manufacture of other chemical products n.e.c.

 

NACE Rev 2 Codes:

2221

-

Manufacture of plastic plates, sheets, tubes and profiles

2120

-

Manufacture of pharmaceutical preparations

2052

-

Manufacture of glues

1320

-

Weaving of textiles

4120

-

Construction of buildings

1419

-

Manufacture of other wearing apparel and accessories n.e.c.

2016

-

Manufacture of plastics in primary forms

1396

-

Manufacture of other technical and industrial textiles

6820

-

Renting and operating of own or leased real estate

2110

-

Manufacture of basic pharmaceutical products

 

NAICS 2012 Codes:

326113

-

Unlaminated Plastics Film and Sheet (except Packaging) Manufacturing

236210

-

Industrial Building Construction

325211

-

Plastics Material and Resin Manufacturing

315280

-

Other Cut and Sew Apparel Manufacturing

313230

-

Nonwoven Fabric Mills

325411

-

Medicinal and Botanical Manufacturing

313210

-

Broadwoven Fabric Mills

531120

-

Lessors of Nonresidential Buildings (except Miniwarehouses)

325520

-

Adhesive Manufacturing

325412

-

Pharmaceutical Preparation Manufacturing

 

US SIC 1987:

3081

-

Unsupported Plastics Film and Sheet

2231

-

Broadwoven Fabric Mills, Wool (Including Dyeing and Finishing)

6512

-

Operators of Nonresidential Buildings

2389

-

Apparel and Accessories, Not Elsewhere Classified

2891

-

Adhesives and Sealants

1541

-

General Contractors-Industrial Buildings and Warehouses

2834

-

Pharmaceutical Preparations

2297

-

Non-woven Fabrics

2821

-

Plastics Materials, Synthetic Resins, and Nonvulcanizable Elastomers

2833

-

Medicinal Chemicals and Botanical Products

 

UK SIC 2007:

2221

-

Manufacture of plastic plates, sheets, tubes and profiles

2120

-

Manufacture of pharmaceutical preparations

2052

-

Manufacture of glues

1320

-

Weaving of textiles

41202

-

Construction of domestic buildings

1419

-

Manufacture of other wearing apparel and accessories n.e.c.

1396

-

Manufacture of other technical and industrial textiles

68209

-

Letting and operating of own or leased real estate (other than Housing Association real estate and conference and exhibition services) n.e.c.

2110

-

Manufacture of basic pharmaceutical products

2016

-

Manufacture of plastics in primary forms

 

Business Description

 

TOYOBO CO., LTD. is a Japan-based manufacturing company that operates in six business segments. The Film and Functional Plastic segment offers packaging films, industrial films, industrial adhesives, engineering plastic and optical functional materials. The Industrial Material segment offers textile materials for automobile uses, super fibers, functional filters and non-woven cloth. The Life Science segment offers biotechnology products, such as enzymes for diagnostic drugs, as well as pharmaceuticals, medical films, medical devices and aquatic films. The Clothing Textile segment offers functional clothing, apparel products, clothing textiles and clothing fibers. The Real Estate segment is involved in the sale, leasing and management of real estate properties. The Others segment is engaged in the design and construction of buildings and machines, the sale of machines, as well as the provision of financial, information, logistics and linen supply services, among others. For the fiscal year ended 31 March 2013, Toyobo Co Ltd revenues decreased 3% to Y339.01B. Net income increased 67% to Y7.64B. Revenues reflect Textile segment decrease of 10% to Y79.21B, Life Science segment decrease of 7% to Y24.84B, Film and Resin segment decrease of 1% to Y137.39B. Net income reflects Real Estate segment income increase of 24% to Y1.68B, Eliminations and Corporate segment loss decrease of 5% to Y3.13B.

More Business Descriptions

Spinning of natural and synthetic textile products; films; advanced functional and biomedical products; environmental related products; electronic materials and industrial materials

Cotton & Synthetic Fibers, Textiles Mfr

Toyobo Co., Ltd. (Toyobo) is a diversified manufacturing company, which offers films, functional polymers, life science, industrial materials and textile products. It operates different business including textiles to specialty businesses such as high performance fibers, functional plastics and seawater desalination membranes. The company operates through four main business segments, namely, Films and Functional Polymers, Industrial Materials, Life Science and Textiles. The Films and Functional Polymers segment comprises industrial films; packaging films; functional polymers such as industrial adhesives, coatings, engineering plastic, photo-sensitive printing plates, acrylate polymers and electronic materials; and other products including rubber processing, pharmaceutical intermediates and coat processing. It offers industrial films for optical use, synthetic paper and other industrial uses; packaging films for food packaging and heat-shrink PET films. In December 2011, the company established a plant for HARDLEN, a chlorinated polypropylene. The company also plans to add new hybrid-type polyester film production capacity; and establish Toyobo Chemicals (Thailand) Co., Ltd. in the coming fiscal years. For the fiscal year ended March 2012, the Film and Functional Polymers segment reported revenue of JPY133,322m, indicating an increase of 5.0% over JPY126,960m for 2011. The segment accounted for 38.1% of the company’s total revenue in 2012. The Industrial Materials segment of the company offers functional fibers, high-performance fibers, functional filters and non-woven fabrics. The functional fibers comprise airbag fabrics and polyester yarn for tire cords; its high-performance fibers include Dyneema, a molecular-weight polyethylene fiber; and Zylon. Toyobo offers functional filters for automobiles, anti-pollution, solvent adsorption materials and units and non-woven fabrics for automobile parts. The segment offers materials for automotive applications such as airbags, interiors and engine filters. The company manufactures airbag fabrics in Japan, China and Thailand. Toyobo also offers various bag filters and air purification filters for thermal power stations and other facilities. In fiscal 2012, the company, along with Toyota Tsusho Corporation, incorporated Toyobo Automotive Textiles (Changshu) Co., Ltd., in China to manufacture airbag fabrics. For the fiscal year ended March 2012, the Industrial Materials segment reported revenue of JPY71,221m, indicating a decrease of 0.34% over JPY71,462m for 2011. The segment accounted for 20.4% of the company’s total revenue in 2012. Through Life Science segment, the company offers bio-products, medical membranes, equipment and devices, pharmaceuticals and water treatment membranes. The segment handles medical services, healthcare and well-being markets. The bio-products of the company include enzymes for diagnostic systems, and diagnostics and reagents for research. In pharmaceuticals, the company undertakes contract manufacturing of injections, pharmaceutical intermediates and raw pharmaceuticals. In medical membranes, equipment and devices category, it offers artificial kidney, hollow fiber and anti-clotting materials, while its water treatment membranes comprise seawater desalination modules. It develops medical and water treatment membranes from fiber processing technologies, and bio-products from fermentation and purification technologies. In fiscal 2012, the company announced the expansion of its injection production capacity along with the introduction of new product lines. For the fiscal year ended March 2012, the Life Science segment reported revenue of JPY31,695m, reflecting an increase of 0.98% over JPY31,386m for 2011. The segment accounted for 9.1% of the company’s total revenue in 2012. The company's Textile segment offers textiles, apparel, fibers for clothes and acrylic fibers. It carries out spinning, weaving, knitting, dyeing, sewing, and wholesale trading of textiles in Japan and overseas. It also provides functional textiles for sportswear, underwear and apparel, and synthetic fibers. The company manufactures apparel under the brand name Munsingwear. It offers a range of materials including nylon, acrylic, polyester, polyurethane elastic fiber, polynosic, cotton, and wool. It offers acrylic fibers under EXLAN brand. For the fiscal year ended March 2012, the Textile segment reported revenue of JPY87,999m, reflecting an increase of 1.34% over JPY86,832m for 2011. The segment accounted for 25.2% of the company’s total revenue in 2012. Toyobo also generates revenue from its Real Estate and Other Business segments. The Real Estate segment of the company carries out the sale, leasing and management of real estate properties. For the fiscal year ended March 2012, the Real Estate segment reported revenue of JPY3,793m, reflecting an increase of 5.3% over JPY3,602m for 2011. The segment accounted for 1.1% of the company’s total revenue in 2012. Other Businesses segment carries out engineering, information processing services and logistics services. For the fiscal year ended March 2012, the Other Businesses segment reported revenue of JPY21,474m, reflecting an increase of 5.62% over JPY20,331m for 2011. The segment accounted for 6.1% of the company’s total revenue in 2012. The company has manufacturing facilities in Japan, Malaysia, China, Thailand, the US, Brazil, El Salvador, Saudi Arabia, Germany and other countries. It conducts research and development activities (R&D) through its R&D center. It handles research themes specific to each business division for efficient production and develops next-generation products and technologies from a medium to long-term perspective. The company spent JPY10,820m on its R&D activities. In January 2013, the company announced to merge two of its wholly owned subsidiaries in the US, namely, Toyobo Specialties (USA) Inc. and Toyobo America, Inc and established a new company Toyobo U.S.A., Inc. It will manage different businesses lines of the company including business operations in North America, offers life science products, sales of functional polymers and industrial materials. In February 2013, through joint research program with Professor Yasuhiro Koike of Keio University, the company developed a polyester-based super retarder film, namely, COSMOSHINE, which helps in eliminating interference fringes. In November 2012, the company's subsidiary, Toyobo Europe GmbH, announced the construction of a plant in Obernburg, Bavaria, Germany. The plant will become operational in August 2013 and manufacture the company's cushion material under BREATHAIR brand. The plant will support the development, manufacture, and sale of the BREATHAIR branded product. In November 2012, the company received Authorized Economic Operator certification from Osaka Customs. Toyobo became the first member of Japan Chemical Fibers Association to hold this status.

 

Toyobo Co., Ltd. (Toyobo) is a manufacturer of films, functional polymers, life science products, industrial materials and textile products. The company's product portfolio comprises bio-products, pharmaceuticals, medical membranes, water treatment membranes, textiles, apparel, fibers for clothes and acrylic fibers. It also offers services comprising real estate leasing business and other businesses, which include the design and construction of buildings and machinery, information processing services and logistics. The company uses different technologies including polymerization, modification, processing and biotechnology. The company, along with its subsidiaries, operates in Japan, China, Thailand, the US, Hong Kong, Korea, Malaysia, Indonesia, Saudi Arabia, Germany, EI Salvador and Brazil. Toyobo is headquartered in Osaka, Japan.The company reported revenues of (Yen) JPY 339,009.00 million during the fiscal year ended March 2013, a decrease of 3.00% from 2012. The operating profit of the company was JPY 14,437.00 million during the fiscal year 2013, a decrease of 7.39% from 2012. The net profit of the company was JPY 7,639.00 million during the fiscal year 2013, an increase of 66.54% over 2012.

Fiber, Yarn, and Thread Mills

 

 

 

 

Financial Data

 

Financials in:

JPY(mil)

 

Revenue:

339,009.0

Net Income:

7,639.0

Assets:

447,445.0

Long Term Debt:

72,278.0

 

Total Liabilities:

309,421.0

 

Working Capital:

8.6

 

 

 

Date of Financial Data:

31-Mar-2013

 

1 Year Growth

-3.0%

66.5%

2.2%

 

 

Market Data

 

Quote Symbol:

3101

Exchange:

Tokyo Stock Exchange

Currency:

JPY

Stock Price:

164.0

Stock Price Date:

07-19-2013

52 Week Price Change %:

59.2

Market Value (mil):

146,040,000.0

 

SEDOL:

6900502

ISIN:

JP3619800000

 

Equity and Dept Distribution:

FY'94-'02 WAS, FY'05-06 Q1 & Q3 o/s & WAS, FY'07 Q3 WAS & o/s, FY'07 AR WAS were estimated. FY'08 Q3 DWAS was estimated and WAS=O/S.

 

Subsidiaries

 

Company

Percentage Owned

Country

Toyobo Kankyo Techno Co Ltd

100%

JAPAN

Toyobo Information System Create Inc

100%

JAPAN

Toyobo do Brasil Indústria Têxtil Ltda.

 

BRAZIL

Toyobo Industrial Material (Thailand) Ltd

100%

THAILAND

Toyobo Biolobics Inc

100%

JAPAN

Toyobo Specialties Trading Co Ltd

100%

JAPAN

Perak Textile Mills Sdn Bhd

 

MALAYSIA

Industrias Unidas S.A.

 

EL SALVADOR

Japan Exlan Co Ltd

80%

JAPAN

Kureha Elastomer Co Ltd

78.6%

JAPAN

Kureha Ltd

100%

JAPAN

Mizushima Aroma Co Ltd

50%

JAPAN

Nippon Dyneema Co Ltd

50%

JAPAN

Sundia Inc

80.2%

JAPAN

Toyobo Engineering Co Ltd

100%

JAPAN

Toyobo Fairtone Co Ltd

100%

JAPAN

Toyobo Living Service Co Ltd

100%

JAPAN

Toyobo Logistics Co Ltd

100%

JAPAN

Toyobo Real Estate Co Ltd

100%

JAPAN

Toyobo Technowool Co Ltd

100%

JAPAN

Toyo Knit Co Ltd

100%

JAPAN

Tsuruga Film Co Ltd

100%

JAPAN

Yuho Co Ltd

100%

JAPAN

Toyobo GFA Co Ltd

100%

JAPAN

Toyobo Knitting Indonesia, PT

96.5%

INDONESIA

Toyobo Textile (Malaysia) Sdn Bhd

80%

MALAYSIA

Toyobo Wool (Malaysia) Sdn Bhd

100%

MALAYSIA

 

 

 

Key Corporate Relationships

Auditor:

KPMG AZSA LLC

 

Auditor:

KPMG AZSA LLC

 

 

 

 

 

The Strategic Initiatives report is created using technology to extract meaningful insights from analyst reports about a company's strategic projects and investments. More about Strategic Initiatives

 

Strategic Initiatives

 

 

Sales and Distribution

(predecessor is the Toyobo China Office), with the objective of strengthening marketing capabilities.The subsidiaries will be involved in manufacturing, processing, and sales of films and functional polymers, industrial materials, life science products, and textiles. As a result of the establishment of these companies, in addition to their activities heretofore of providing marketing support and gathering information, they will be able to provide operational support, including sales activities, technological services, and product introductions as well as technological guidance as the representative of Toyobo in the respective countries. Looking ahead, these subsidiaries will strengthen their capabilities for marketing activities in Europe and China, enhance collaboration with local partners, and accelerate the development of Toyobo's overseas activities.Feb 06, 2012Toyobo Reports Revenue Of JPY258.8 Billion For Nine Months Ended December 31, 2011Toyobo Co., Ltd.

 

 

Strengths/Weaknesses (SWOT)

 

 

Helpful
to achieving the objective

Harmful
to achieving the objective

Internal Origin
(attributes of the organization)

Strengths

·        Improved Profitability

·        Strong Research and Development Activities

·        Diversified Business Operations

Weaknesses

·        Decline in Inventory Turnover

External Origin
(attributes of the environment)

Opportunities

·        Growing Paint and Coatings Industry

·        Positive Outlook of Petrochemical Industry

·        Key Business Initiatives

Threats

·        Intense Competition

·        Raw Material Procurement Risks

·        Government Regulations

 

 

Overview

 

Toyobo Co., LTD. (Toyobo) is a diversified manufacturing company, which provides films, functional polymers, life science, industrial materials and textile products. Its products find applications in various markets incuding automotive, life science, electronics and information display. The company leverages from its diversified business operations coupled with wide geographical presence. Decline in inventory turnover is a conern for the company. The company may get benefied from its key business initiatives, positive outlook of petrochemical industry and growing paint and coatings industry. However, the government regulations and growing competition, could hamper the company's business operations.

 

 

Strengths

 

Improved Profitability

 

The company reported an operating profit of JPY15,589m during the fiscal year ended 2012, reflecting an increase of 33.09% over that in 2011. The operating margin has increased to 4.46% in 2012 from 3.45% in 2011, which may indicate management's high focus on improving profitability. The increase in operating profit led to increased net profit. It reported net profit of JPY4,587m during the fiscal year ended 2012, reflecting an increase of 10.34% over that in 2011. The increased operating and net profits resulted in increased profitability ratios. The company also reported increased return on equity (ROE) in 2012. Its ROE was 3.51% for the fiscal year ended 2012, compared to 3.31% in 2011. Its return on capital employed was 5.67% in the fiscal year ended 2012, compared to 4.18% in 2011. Its return on assets and return on fixed assets were 1.05% and 5.99%, respectively in 2012 compared to 0.94% and 4.31% in 2011. Increasing profitability ratios indicate the company’s sturdy performance and its ability to deliver returns expected by its shareholders.

 

Strong Research and Development Activities

 

The company’s focus on research and development activities helps in improving its product innovation and provides a source of future revenues. Since its inception, the company has developed various products. One of such is the development of the world’s first cosmetic ingredient extracted from soybean germ that contain polyamine. The company’s R&D activities are conducted through two components, namely, the divisional R&D department that handles research themes specific to each business division to generate products in relatively short periods of time and the corporate R&D department that develops next-generation products and technologies. The corporate division comprise of three divisions. The first division carries out core technology research aimed at gaining future advantage in basic and cutting-edge technology. The second division undertakes project research to hasten commercialization. The third division is the infrastructure division, it coordinates company-wide research and arranges analytical technique and simulation technology. The corporate department also maintains active contact with universities, corporations and research institutions. For the fiscal year ended 2012, the company has spent around JPY10,685 towards its research and development activities, reflecting an increase of 1.8% over the previous year.

 

Diversified Business Operations

 

The diversified business operations helps the company in minimizing the impact of market volatility in one particular business unit and provide economic stability. Toyobo has diversified its operations in terms of the number of industries and markets served. The company operates through various business segments: Films and functional polymers, Industrial materials, Life science, Textiles, Real estate, and Other businesses. The Film and functional polymers segment offers industrial films, packaging films, and functional polymers such as industrial adhesives, coatings, engineering plastic and acrylate polymers. Through Industrial material segment, the company offers functional fibers, high-performance fibers, functional filters and non-woven fabrics. Its Life science segment provides bio products, pharmaceuticals, medical membranes, equipment and devices, and water treatment membranes. The company’s textile segment specializes in offering functional textiles, apparel, fibers for clothes and acrylic fibers. Real estate and Other businesses segment carries out the engineering, real estate, information processing services, and logistics services. For the fiscal year ended March 2012, the company generated 38.1% of its total revenue from Film and functional polymers segment, followed by 25.17% from Textiles segment, 20.37% from Industrial material segment, 9.06% from Life science segment, 6.14% from Other businesses segment and 1.08% from Real estate segment. Extensive coverage of various markets would lead to improved sales, greater profit margins, economies of scale and recognition on a worldwide basis. Geographical diversity also enables the company to mitigate various risks associated with over-dependence on a specific market. Headquartered in Japan, the company has operations in Thailand, Indonesia, Saudi Arabia, El Salvador, Brazil, China, Taiwan, Korea, Hong Kong, Germany and the US.

 

 

Weaknesses

 

Decline in Inventory Turnover

 

The company's declined inventory turnover hampers its profitability and increases its inventory cost. For the fiscal year ended March 2012, the company reported inventory turnover ratio of 3.54, as compared to 4.016 in 2011. As of March 2012, the value of the company's inventory totaled to JPY77,572m, as compared to JPY65,988m in 2011. Decline in inventory turnover reflects that the company would require 103.02 days to sell its inventory on hand, as compared to 90.88 days in 2011. The increase in days of inventory on hand indicates the company’s weak sales or ineffective buying. The declining inventory turnover ratio affects the company‘s performance and raises its inventory cost such as warehouse and material handling cost.

 

 

Opportunities

 

Growing Paint and Coatings Industry

 

Through Films and Functional Polymers division, Toyobo serves resin manufacturers, paint formulators and additive producers across the world. Paints and coating industry is recording substantial growth as a result of the growing infrastructure industry. According to industry estimates, the worldwide demand for paint and coatings is expected to increase 5.4% annually through 2015 to 45.5 million metric tons, with a total value of approximately $140 billion. Asia-Pacific is estimated to be the major market for paints and coatings. Within the industry, industrial paints are expected to be the major segment as a result of rising infrastructure and industrial construction spending across the world. The industrial coatings market is projected to be valued around $55 billion by 2020. Toyobo could gain from its building blocks and specialty surfactants used to deliver sustainable products.

 

Positive Outlook of Petrochemical Industry

 

Toyobo could be benefited from the potential global petrochemicals market. According to the in-house research reports, the global petrochemicals industry was valued at $733.4 billion, and it is expected to grow at a rate of 8.8% to reach $1699 billion by 2020. Global market for polyethylene is expected to reach $186 billion in 2020. In addition, total world market for polypropylene is expected to grow at a rate of 8.4% during 2010-2020 to reach $109.1 billion. Such growth in petrochemical sector is expected to be driven by Asia Pacific, and Middle East and Africa regions. Asia Pacific’s petrochemicals market is expected to register CAGR of 10.2% during 2010-2020 to reach $1070 billion. Such a strong outlook of the petrochemical industry could help the company to expand its geographic operations and explore untapped markets to bolster top-line growth.

 

Key Business Initiatives

 

Strategic initiative such as expansions and new product developments helps the company in enhancing its business performance and in attracting new customers. In February 2013, through joint research program with Professor Yasuhiro Koike of Keio University, the company developed a polyester-based super retarder film, namely, COSMOSHINE, which helps for elimination of interference fringes. In January 2013, the company announced to merge two of its wholly owned subsidiaries in the US, namely, Toyobo Specialties (USA) Inc. and Toyobo America, Inc and established a new company Toyobo U.S.A., Inc. The newly formed subsidiary will manage different businesses lines of the company including business operations in North America, offers life science products, sales of functional polymers and industrial materials. In November 2012, the company's subsidiary, Toyobo Europe GmbH, announced its plan to construct a plant in Obernburg, Bavaria, Germany. The plant will become operational in August 2013 and will manufacture the company's cushion material under BREATHAIR brand. The new plant will undertake the development, manufacture and sale of the BREATHAIR branded product. In the same month, the company developed a tactile sense measuring technology for quantifying comfort-ability. Using this technology, the company also developed BREATHLEATHER, which is an artificial leather for automotive seats that does not feel sticky. In September 2012, the company developed PHYTOPOLYAMINE-S, an ingredient for cosmetics derived from soybean germ that contain polyamine. In July 2012, the company established a joint venture in Thailand with Mitsubishi Corporation for the manufacturing and sale of VYLON co-polyester resin. The production is scheduled to commence in January 2014. In April 2012, the company announced to establish a sales company for air bag fabrics in Michigan, the US, to strengthen its business in North America. The total investment for this business is approximately one billion JPY. In February 2012, the company established a subsidiary, Toyobo Europe GmbH in Germany to undertake the manufacturing, processing, and sale of films and functional polymers, industrial materials, life science products, and textiles in the European market. In the same month, the company established another subsidiary, Toyobo China Co., Ltd. (Toyobo China) for strengthening its marketing capabilities in China. Toyobo China will sell films and functional polymers, industrial materials, life science products, and textiles in China.

 

 

Threats

 

Intense Competition

 

The competition in the chemical industry is fierce. With rising competition, the chemical industry has witnessed consolidation, wherein the smaller entities are being acquired or merged with major players. To survive and succeed in a stiff competitive environment, it is very important for the company to distinguish its product and service offerings through a clear and unique value proposition. Some of the major competitors of the company include Toray Industries, Inc., Nipro Corporation, Asahi Kasei Corporation, and Mitsui Chemicals, Inc, among others. Some of the company’s competitors have substantially greater financial, marketing and distribution resources. If the company is unable to maintain its product quality and customer loyalty, such intense competition could reduce the sales volume of the company, hampering its market position. Rising competition may also force the company to reduce its prices, which in turn may adversely affect its margins.

 

Raw Material Procurement Risks

 

The company’s production schedule and production costs could adversely affected with fluctuations in the supply and prices of raw materials. The company employs various raw materials in production activities. Though the company strives to assure stable supply of the raw materials, its operations could be affected by factors such as tightened supplies, delay in procurement and increased prices of raw materials. The fluctuating raw materials prices could affect the company’s business. The prices and availability of these raw materials keep fluctuating from time to time, due to market demand. Increase in the cost of these raw materials is usually caused by escalating energy and related feedstock costs, increased levels of global demand, and improved levels of supplier pricing discipline. Any reduction in the supply or increase in the cost of the raw materials might hamper the company's ability to develop its products and increase the cost of production.

 

Government Regulations

 

The company is subjected to numerous regulations related to environment, production, manufacture, storage, distribution, sale and use of products. It is exposed to potential liability and increase in operating costs related to these regulations, besides changes in tax, fiscal, governmental and other regulatory policies. The potential cost related to environmental and product registration laws and regulations is uncertain due to factors such as the unknown magnitude and type of possible contamination and clean-up costs, the complexity and evolving nature of laws and regulations, and the time for and cost of compliance. Such regulations could impact the overall operations of the company.

 

 

Corporate Family      

 

Corporate Structure News:

 

Toyobo Co Ltd
Total Corporate Family Members: 33

 

 

Company Name

Company Type

Location

Country

Industry

Sales
(USD mil)

Employees

Toyobo Co Ltd

Parent

Osaka-Shi

Japan

Rubber and Plastic Product Manufacturing

4,085.9

10,566

Acquisition of Spinreact Sa proposed/announced.See corporate structure news on Toyobo Co Ltd for details

Toyobo do Brasil Indústria Têxtil Ltda.

Subsidiary

São Paulo, SP

Brazil

Textile Manufacturing

 

1,020

Cosmo Electronics Co.,Ltd.

Subsidiary

Yokkaichi, Mie

Japan

Semiconductor and Other Electronic Component Manufacturing

30.7

310

Kureha Ltd.

Subsidiary

Shiga

Japan

Textile Manufacturing

 

180

Toyobo Kureha America Co., Ltd.

Subsidiary

Cincinnati, OH

United States

Textile Manufacturing

9.1

40

Toyobo Textile (Malaysia) Sdn. Bhd.

Subsidiary

Kuala Kangsar, Perak

Malaysia

Textile Manufacturing

13.8

101

Tsuruga Film Co.,Ltd.

Subsidiary

Tsuruga, Fukui

Japan

Rubber and Plastic Product Manufacturing

30.9

93

Toyobo Stc (Shanghai)Co.,Ltd.

Subsidiary

Shanghai, Shanghai

China

Chemical Wholesale

15.3

41

Toyobo Industrial Material (Thailand) Limited

Subsidiary

Wattana, Bangkok

Thailand

Textile Manufacturing

 

11

Toyobo America Inc.

Subsidiary

New York, NY

United States

Research and Development Services

1.7

6

Toyobo Specialties Trading Co.,Ltd.

Subsidiary

Osaka, Osaka

Japan

Chemical Wholesale

1,104.6

 

Toyobo Stc (Thailand) Company Limited

Subsidiary

Sathon, Bangkok

Thailand

Machinery Wholesale

18.2

25

Toyobo Apparel Systems K.K.

Subsidiary

Osaka, Osaka

Japan

Clothing and Apparel Manufacturing

66.1

 

Japan Exlan Co., Ltd.

Subsidiary

Osaka, Osaka

Japan

Textile Manufacturing

206.5

 

Exlan Technical Center Co.,Ltd.

Subsidiary

Okayama, Okayama

Japan

Ambulatory Services

11.9

89

Toyobo Engineering Co.,Ltd.

Subsidiary

Osaka, Osaka

Japan

Specialty Construction Trade Contractors

196.3

 

Toyo Cloth Co.,Ltd.

Subsidiary

Osaka, Osaka

Japan

Textile Manufacturing

92.8

 

Kureha Elastomer Co.,Ltd.

Subsidiary

Osaka, Osaka

Japan

Rubber and Plastic Product Manufacturing

84.4

 

Toyobo Logistics Co.,Ltd.

Subsidiary

Osaka, Osaka

Japan

Commercial Real Estate Leasing

83.2

 

Yuho Co., Ltd.

Subsidiary

Osaka, Osaka

Japan

Textile Manufacturing

59.5

 

Toyobo Kankyo Techno Co., Ltd.

Subsidiary

Osaka, Osaka

Japan

Textile Manufacturing

48.4

 

Toyo Knit Co.,Ltd.

Subsidiary

Yokkaichi, Mie

Japan

Clothing and Apparel Manufacturing

46.9

 

Kyushu Toyo Knitting Co.,Ltd.

Subsidiary

Kirishima, Kagoshima

Japan

Clothing and Apparel Manufacturing

17.4

94

Toyobo Technowool Co.,Ltd.

Subsidiary

Osaka, Osaka

Japan

Clothing and Apparel Manufacturing

46.5

 

Toyobo Real Estate Co.,Ltd.

Subsidiary

Osaka, Osaka

Japan

Commercial Real Estate Leasing

44.9

 

Toyobo Fairtone Co.,Ltd.

Subsidiary

Osaka, Osaka

Japan

Home Furnishings Wholesale

43.7

 

Toyobo Information System Create Co.,Ltd.

Subsidiary

Osaka, Osaka

Japan

Data Processing

29.8

 

Perak Textile Mills Sdn Bhd

Subsidiary

Kuala Kangsar, Perak

Malaysia

Textile Manufacturing

13.6

 

Miyuki Keori K.K.

Subsidiary

Nagoya, Aichi

Japan

Clothing and Apparel Manufacturing

8.8

 

Miyuki Hambai Co.,Ltd.

Subsidiary

Nagoya, Aichi

Japan

Clothing and Apparel Manufacturing

46.4

 

Miyuki Elex Co.,Ltd.

Subsidiary

Itami, Hyogo

Japan

Electrical Equipment and Appliances Manufacturing

44.2

 

Lan Clothing, K.K.

Subsidiary

Higashi-Osaka, Osaka

Japan

Laundry Services

8.5

 

Industrias Unidas S.A.

Subsidiary

San Salvador

El Salvador

Textile Manufacturing

 

 

 

 

 

 

Competitors Report

 

CompanyName

Location

Employees

Ownership

Asahi Kasei Corporation

Tokyo, Japan

25,085

Public

Fuji Electric Co Ltd

Shinagawa-Ku, Japan

24,956

Public

Mitsui Chemicals, Inc.

Minato-Ku, Japan

12,846

Public

NIPRO CORPORATION

Osaka-Shi, Japan

19,327

Public

Toray Industries Inc

Chuo-Ku, Japan

42,584

Public

 

 

Executives Report

 

 

Board of Directors

Name

Title

Function

Kazumasa Koyama

 

Managing Executive Officer, Chief Director of Functional Material Business, Director

Director/Board Member

Biography:

Mr. Kazumasa Koyama has been serving as Managing Executive Officer, Chief Director of Functional Material Business and Director in TOYOBO CO., LTD. since April 2012. He joined the Company in April 1974. His previous titles include Senior Director of Functional NW Business and Director of Spunbond Business.

Age: 61

Toshiyuki Matsui

 

Executive Officer, Chief Director of Bio & Medical Business, Manager of Bio & Medical Planning Management Office, Senior Director of Functional Film Business, Director

Director/Board Member

 

Biography:

Mr. Toshiyuki Matsui has been serving as Executive Officer, Chief Director of Bio & Medical Business, Manager of Bio & Medical Planning Management Office, Senior Director of Functional Film Business and Director in TOYOBO CO., LTD. since June 2012. He joined the Company in April 1974. His previous titles include Senior Director of Functional Material Business and Director of Super Fiber Business.

Age: 61

Fumiaki Miyoshi

 

Board Member

Director/Board Member

 

Seiji Narahara

 

Executive Officer, Chief Director of Global Promotion, Manager of Business Planning Office, Director

Director/Board Member

 

Biography:

Mr. Seiji Narahara has been serving as Executive Officer, Chief Director of Global Promotion, Manager of Business Planning Office and Director in TOYOBO CO., LTD. since June 2011. He joined the Company in January 1988. His previous title was Director of Finance.

Age: 56

Michio Ogimura

 

Independent Director

Director/Board Member

 

Biography:

Mr. Michio Ogimura has been serving as Independent Director in TOYOBO CO., LTD. since June 2011. He is also working for Sumitomo Corporation. He used to serve as Vice President and Managing Executive Officer in Sumitomo Corporation.

Age: 65

Ryuzo Sakamoto

 

President, Executive President, Representative Director

Director/Board Member

 

Biography:

Mr. Ryuzo Sakamoto has been serving as Executive President, President and Representative Director of TOYOBO CO., LTD. since June 2005. He joined the Company in April 1972. His previous titles include Director of 2nd Textile Business, Director of Textile Technology and Procurement and Manager of Business Planning Office in the Company.

Age: 65

Shigeki Sano

 

Executive Officer, Chief Director of Functional Fiber Business, Director

Director/Board Member

 

Biography:

Mr. Shigeki Sano has been serving as Executive Officer, Chief Director of Functional Fiber Business and Director in TOYOBO CO., LTD. since June 2012. He joined the Company in April 1975. His previous titles include Senior Director of Functional Materials Business and Director of Super Fiber Business.

Age: 60

Hiroshi Takahashi

 

Managing Executive Officer, Representative Director

Director/Board Member

 

Biography:

Mr. Hiroshi Takahashi has been serving as Managing Executive Officer and Representative Director in TOYOBO CO., LTD. since April 1, 2013. He joined the Company in April 1973. His previous titles include Executive Officer and Director of Finance and Accounting.

Age: 62

Kunio Yano

 

Executive Officer, Senior Director of Real Estate Business, President of Tokyo Office, Director

Director/Board Member

 

Biography:

Mr. Kunio Yano has been serving as Executive Officer, Senior Director of Real Estate Business, President of Tokyo Office and Director in TOYOBO CO., LTD. since June 2012. He joined the Company in April 1975. His previous titles include Director of General Affairs, Director of Legal Affairs and President of Nagoya Office.

Age: 62

 

Executives

 

Name

Title

Function

Ryuzo Sakamoto

 

President, Executive President, Representative Director

President

Biography:

Mr. Ryuzo Sakamoto has been serving as Executive President, President and Representative Director of TOYOBO CO., LTD. since June 2005. He joined the Company in April 1972. His previous titles include Director of 2nd Textile Business, Director of Textile Technology and Procurement and Manager of Business Planning Office in the Company.

Age: 65

Kazumasa Koyama

 

Managing Executive Officer, Chief Director of Functional Material Business, Director

Division Head Executive

 

Biography:

Mr. Kazumasa Koyama has been serving as Managing Executive Officer, Chief Director of Functional Material Business and Director in TOYOBO CO., LTD. since April 2012. He joined the Company in April 1974. His previous titles include Senior Director of Functional NW Business and Director of Spunbond Business.

Age: 61

Toshiyuki Matsui

 

Executive Officer, Chief Director of Bio & Medical Business, Manager of Bio & Medical Planning Management Office, Senior Director of Functional Film Business, Director

Division Head Executive

 

Biography:

Mr. Toshiyuki Matsui has been serving as Executive Officer, Chief Director of Bio & Medical Business, Manager of Bio & Medical Planning Management Office, Senior Director of Functional Film Business and Director in TOYOBO CO., LTD. since June 2012. He joined the Company in April 1974. His previous titles include Senior Director of Functional Material Business and Director of Super Fiber Business.

Age: 61

Fumiaki Miyoshi

 

Board Member

Division Head Executive

 

Seiji Narahara

 

Executive Officer, Chief Director of Global Promotion, Manager of Business Planning Office, Director

Division Head Executive

 

Biography:

Mr. Seiji Narahara has been serving as Executive Officer, Chief Director of Global Promotion, Manager of Business Planning Office and Director in TOYOBO CO., LTD. since June 2011. He joined the Company in January 1988. His previous title was Director of Finance.

Age: 56

Hisao Nishinaka

 

Executive Officer, Manager of Fiber Planning Management Office

Division Head Executive

 

Teruo Ohigashi

 

Executive Officer, Director of Engineering, Director of Environment & Safety, Manager of Quality Assurance Office

Division Head Executive

 

Yuji Oita

 

Executive Officer, Senior Manager of Intellectual Property Office

Division Head Executive

 

Shinichi Onizuka

 

Managing Executive Officer, Senior Manager of Production Technology Office

Division Head Executive

 

Masakazu Saito

 

Executive Officer, Senior Director of China Business

Division Head Executive

 

Shigeki Sano

 

Executive Officer, Chief Director of Functional Fiber Business, Director

Division Head Executive

 

Biography:

Mr. Shigeki Sano has been serving as Executive Officer, Chief Director of Functional Fiber Business and Director in TOYOBO CO., LTD. since June 2012. He joined the Company in April 1975. His previous titles include Senior Director of Functional Materials Business and Director of Super Fiber Business.

Age: 60

Hiroyuki Sato

 

Executive Officer, Senior Director of Functional Fiber Business, Senior Dir of Functional Material Business

Division Head Executive

 

Jiro Suwa

 

Executive Officer, Senior Manager of Procurement Office

Division Head Executive

 

Toshitake Suzuki

 

Executive Officer, Senior Director of Industrial Film Business

Division Head Executive

 

Hiroshi Takahashi

 

Managing Executive Officer, Representative Director

Division Head Executive

 

Biography:

Mr. Hiroshi Takahashi has been serving as Managing Executive Officer and Representative Director in TOYOBO CO., LTD. since April 1, 2013. He joined the Company in April 1973. His previous titles include Executive Officer and Director of Finance and Accounting.

Age: 62

Shigeo Takenaka

 

Executive Officer, Chief Director of Specialty Chemical

Division Head Executive

 

Shinichi Teshima

 

Executive Officer, Senior Director of Bio Business

Division Head Executive

 

Hitoshi Ueno

 

Executive Officer, Director of Research Development Planning, Manager of Business Development Planning Office, Manager of General Research Center, Manager of Corporate Research Office

Division Head Executive

 

Kunio Yano

 

Executive Officer, Senior Director of Real Estate Business, President of Tokyo Office, Director

Division Head Executive

 

Biography:

Mr. Kunio Yano has been serving as Executive Officer, Senior Director of Real Estate Business, President of Tokyo Office and Director in TOYOBO CO., LTD. since June 2012. He joined the Company in April 1975. His previous titles include Director of General Affairs, Director of Legal Affairs and President of Nagoya Office.

Age: 62

Yukihiro Sogabe

 

Corporate Executive Officer

Administration Executive

 

Hiroshi Imanaka

 

Corporate Auditor

Accounting Executive

 

Hiroshi Nishiura

 

Corporate Auditor

Accounting Executive

 

Setsuo Shimomichi

 

Corporate Auditor

Accounting Executive

 

Kazuyuki Yabuki

 

Corporate Auditor

Accounting Executive

 

Yoshikazu Akasaka

 

Director of Tokyo General Affairs

Investor Relations Executive

 

 

 

Significant Developments

 

Toyobo Co Ltd to Issue Year-end Dividend for FY 2013

May 24, 2013


Toyobo Co Ltd announced that it has decided to issue a year-end dividend of JPY 3.5 per share, in line with the latest dividend forecast of JPY 3.5 per share, disclosed on May 9, 2013, to all the shareholders of record as of March 31, 2013, effective June 28, 2013.

Toyobo Co Ltd to Withdraw from Polyester Tire Cord Business- Response

May 12, 2013


Response reported that Toyobo Co Ltd announced that it will withdraw from polyester tire cord business in late December 2013.

Japan Wool Textile Co Ltd to Acquire Shares in ASHIMORI INDUSTRY CO LTD from Toyobo Co Ltd

Apr 10, 2013


ASHIMORI INDUSTRY CO LTD announced that Japan Wool Textile Co Ltd will acquire 9,201,000 shares in ASHIMORI INDUSTRY CO LTD from Toyobo Co Ltd, at the price of JPY 138 per share (JPY 1,269,738,000 in total) on April 24, 2013. As a result, Japan Wool Textile will increase its stake in ASHIMORI INDUSTRY from a 0.8% stake (469 voting rights) to a 17.2% stake (9,670 voting rights) and become the top shareholder, while Toyobo will decrease its stake from a 16.4% stake (9,201 voting rights) to a 0% stake, effective April 24, 2013.

R&I Affirms Toyobo Co Ltd's Rating at "BBB+"; Rating Outlook Stable

Dec 04, 2012


Rating and Investment Information, Inc. (R&I) announced that it has affirmed the rating on Toyobo Co., Ltd. at "BBB+". The rating outlook is stable.

Fujibo Holdings Inc's Subsidiary to Take Over Plant from Toyobo Co., Ltd.

Oct 15, 2012


Fujibo Holdings Inc announced that its subsidiary, Yanai Chemical Industry CO.,LTD., will take over takeo plant and related assets, from Toyobo Co., Ltd., effective April 1, 2013. The price will be decided later.

Toyobo Co., Ltd. Lowers Consolidated Mid-year and Full-year Outlook for FY 2013

Aug 06, 2012


Toyobo Co., Ltd. announced that it has lowered the consolidated mid-year outlook for revenue from JPY 180,000 million to JPY 175,000 million, operating profit from JPY 11,500 million to JPY 7,000 million, ordinary profit from JPY 10,500 million to JPY 6,000 million, net profit from JPY 5,000 million to JPY 2,300 million and earning per share from JPY 5.64 to JPY 2.59 for the fiscal year ending March 31, 2013. The Company has also lowered the consolidated full-year outlook for revenue from JPY 365,000 million to JPY 355,000 million, operating profit from JPY 24,000 million to JPY 18,000 million, ordinary profit from JPY 21,000 million to JPY 15,000 million, net profit from JPY 10,000 million to JPY 6,400 million and earning per share from JPY 11.28 to JPY 7.22 for the fiscal year ending March 31, 2013. The negative outlook is mainly due to less-than-expected sales of film and functional resin.

 

 

News

 

TOYOBO CO LTD : Consolidated Financial Report for the First Quarter ended June 30, 2013
4 Traders (174 Words)

05-Aug-2013

Tokyo Most Actives
Nikkei English News (590 Words)

05-Aug-2013

Tokyo Stock Exchange: closing price list -9-
Japan Economic Newswire (234 Words)

05-Aug-2013

Toyobo Surges On 500% Net Profit Rise
Nikkei English News (61 Words)

05-Aug-2013

Toyobo Expects This FY Group Net Profit Y9.50B
Nikkei English News (43 Words)

05-Aug-2013

Toyobo 1Q Grp Net Pft Y2.96B Vs Y492.00M Pft Yr Earlier
Nikkei English News (57 Words)

05-Aug-2013

Tokyo Stock Exchange: morning price list -9-
Japan Economic Newswire (234 Words)

04-Aug-2013

Tokyo Stock Exchange: closing price list -9-
Japan Economic Newswire (234 Words)

02-Aug-2013

WIPO PUBLISHES PATENT OF TOYOBO FOR "STRETCHED POLYPROPYLENE FILM" (JAPANESE INVENTORS)
U.S. Fed News (245 Words)

02-Aug-2013

Toyobo Buys Spanish Peer To Widen Reach
Nikkei English News (157 Words)

01-Aug-2013

TOYOBO CO., LTD. : Toyobo Acquires Spains Spinreact S.A., a Global Manufacturer and Marketer of Diagnostic Reagents and Instruments Marking the Acceleration of Toyobos Overseas Expansion Strategy in Biotechnology
Euroland (440 Words)

31-Jul-2013



Annual Income Statement

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           

 

31-Mar-2013

31-Mar-2012

31-Mar-2011

31-Mar-2010

31-Mar-2009

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal
31-Mar-2013

Updated Normal
31-Mar-2012

Updated Normal
31-Mar-2011

Updated Normal
31-Mar-2010

Updated Normal
31-Mar-2009

Filed Currency

JPY

JPY

JPY

JPY

JPY

Exchange Rate (Period Average)

82.970472

78.961215

85.691434

92.941082

100.484331

Auditor

KPMG AZSA LLC

KPMG AZSA LLC

KPMG LLP

KPMG LLP

KPMG LLP

Auditor Opinion

Unqualified with Explanation

Unqualified with Explanation

Unqualified

Unqualified with Explanation

Unqualified with Explanation

 

 

 

 

 

 

    Net Sales

4,085.9

4,426.3

3,974.4

3,429.8

3,655.0

Revenue

4,085.9

4,426.3

3,974.4

3,429.8

3,655.0

Total Revenue

4,085.9

4,426.3

3,974.4

3,429.8

3,655.0

 

 

 

 

 

 

    Cost of Revenue

3,226.4

3,480.2

3,092.3

2,729.6

2,984.9

Cost of Revenue, Total

3,226.4

3,480.2

3,092.3

2,729.6

2,984.9

Gross Profit

859.5

946.1

882.2

700.2

670.1

 

 

 

 

 

 

    Selling/General/Administrative Expense

332.0

352.9

307.0

282.7

305.4

    Labor & Related Expense

203.2

226.0

208.8

184.2

188.2

Total Selling/General/Administrative Expenses

535.3

578.9

515.8

466.9

493.6

Research & Development

118.4

135.3

122.5

109.9

105.1

    Amortization of Acquisition Costs

-11.4

-12.7

-11.4

-10.2

-9.7

Depreciation/Amortization

-11.4

-12.7

-11.4

-10.2

-9.7

    Restructuring Charge

-

-

-

0.0

117.3

    Litigation

16.1

28.3

28.3

22.2

16.7

    Impairment-Assets Held for Use

20.1

0.0

4.5

3.4

7.3

    Impairment-Assets Held for Sale

-

-

52.5

5.1

15.9

    Other Unusual Expense (Income)

7.1

18.8

33.2

26.2

25.0

Unusual Expense (Income)

43.3

47.1

118.5

56.9

182.2

    Other Operating Expense

-

0.0

-

-

-

Other Operating Expenses, Total

-

0.0

-

-

-

Total Operating Expense

3,911.9

4,228.9

3,837.7

3,353.2

3,756.2

 

 

 

 

 

 

Operating Income

174.0

197.4

136.7

76.6

-101.2

 

 

 

 

 

 

        Interest Expense - Non-Operating

-22.8

-26.1

-29.4

-30.2

-30.8

    Interest Expense, Net Non-Operating

-22.8

-26.1

-29.4

-30.2

-30.8

        Interest Income - Non-Operating

-

2.6

2.7

3.2

3.7

        Investment Income - Non-Operating

59.0

19.2

11.2

-1.0

-25.0

    Interest/Investment Income - Non-Operating

59.0

21.8

13.9

2.2

-21.3

Interest Income (Expense) - Net Non-Operating Total

36.2

-4.3

-15.5

-28.0

-52.1

Gain (Loss) on Sale of Assets

-19.1

-16.4

-22.2

-19.0

13.6

    Other Non-Operating Income (Expense)

-37.1

-39.2

-40.8

-32.4

-66.8

Other, Net

-37.1

-39.2

-40.8

-32.4

-66.8

Income Before Tax

154.0

137.6

58.3

-2.7

-206.4

 

 

 

 

 

 

Total Income Tax

53.0

65.1

-1.1

-28.1

-61.8

Income After Tax

101.0

72.5

59.3

25.4

-144.6

 

 

 

 

 

 

    Minority Interest

-8.9

-14.4

-10.8

-2.8

20.2

Net Income Before Extraord Items

92.1

58.1

48.5

22.5

-124.4

Net Income

92.1

58.1

48.5

22.5

-124.4

 

 

 

 

 

 

    Miscellaneous Earnings Adjustment

0.0

-

0.0

0.0

0.0

Total Adjustments to Net Income

0.0

-

0.0

0.0

0.0

Income Available to Common Excl Extraord Items

92.1

58.1

48.5

22.5

-124.4

 

 

 

 

 

 

Income Available to Common Incl Extraord Items

92.1

58.1

48.5

22.5

-124.4

 

 

 

 

 

 

Basic/Primary Weighted Average Shares

887.0

886.7

757.4

726.4

697.9

Basic EPS Excl Extraord Items

0.10

0.07

0.06

0.03

-0.18

Basic/Primary EPS Incl Extraord Items

0.10

0.07

0.06

0.03

-0.18

Dilution Adjustment

-

0.0

0.0

0.0

0.0

Diluted Net Income

92.1

58.1

48.5

22.5

-124.4

Diluted Weighted Average Shares

887.0

886.7

757.9

766.7

697.9

Diluted EPS Excl Extraord Items

0.10

0.07

0.06

0.03

-0.18

Diluted EPS Incl Extraord Items

0.10

0.07

0.06

0.03

-0.18

Dividends per Share - Common Stock Primary Issue

0.04

0.04

0.04

0.04

0.03

Gross Dividends - Common Stock

37.5

39.4

36.3

28.2

24.3

Interest Expense, Supplemental

22.8

26.1

29.4

30.2

30.8

Depreciation, Supplemental

159.6

246.6

223.0

219.7

211.0

Total Special Items

50.9

50.8

129.3

65.8

158.9

Normalized Income Before Tax

204.9

188.3

187.5

63.0

-47.5

 

 

 

 

 

 

Effect of Special Items on Income Taxes

21.5

30.1

49.2

26.6

59.0

Inc Tax Ex Impact of Sp Items

74.5

95.2

48.2

-1.5

-2.7

Normalized Income After Tax

130.4

93.2

139.3

64.6

-44.7

 

 

 

 

 

 

Normalized Inc. Avail to Com.

121.5

78.8

128.5

61.7

-24.5

 

 

 

 

 

 

Basic Normalized EPS

0.14

0.09

0.17

0.08

-0.04

Diluted Normalized EPS

0.14

0.09

0.17

0.08

-0.04

Amort of Acquisition Costs, Supplemental

-11.4

-12.7

-11.4

-10.2

-9.7

Research & Development Exp, Supplemental

120.1

137.0

124.1

110.8

106.2

Reported Operating Profit

205.9

231.8

243.8

123.4

111.7

Reported Ordinary Profit

187.1

199.2

198.9

80.1

20.5

Normalized EBIT

217.3

244.6

255.2

133.6

81.1

Normalized EBITDA

365.5

478.4

466.8

343.1

282.4

    Current Tax - Total

28.8

20.5

-

-

-

Current Tax - Total

28.8

20.5

-

-

-

    Deferred Tax - Total

24.2

44.6

-

-

-

Deferred Tax - Total

24.2

44.6

-

-

-

Income Tax - Total

53.0

65.1

-

-

-

Interest Cost - Domestic

13.7

14.5

15.2

14.4

13.4

Service Cost - Domestic

27.8

27.6

25.5

25.7

24.5

Prior Service Cost - Domestic

0.9

1.0

-3.2

-3.6

-3.3

Expected Return on Assets - Domestic

-13.9

-14.0

-13.5

-10.0

-11.2

Actuarial Gains and Losses - Domestic

21.7

32.1

26.6

27.8

16.2

Transition Costs - Domestic

-

-

-

-

0.0

Other Pension, Net - Domestic

22.7

21.2

18.3

17.0

15.8

Domestic Pension Plan Expense

72.9

82.4

68.9

71.3

55.3

Defined Contribution Expense - Domestic

-

1.3

0.7

0.7

0.7

Total Pension Expense

72.9

83.7

69.6

71.9

56.0

Discount Rate - Domestic

2.00%

2.00%

2.00%

2.00%

2.00%

Expected Rate of Return - Domestic

3.50%

3.50%

3.50%

2.50%

2.50%

Total Plan Interest Cost

13.7

14.5

15.2

14.4

13.4

Total Plan Service Cost

27.8

27.6

25.5

25.7

24.5

Total Plan Expected Return

-13.9

-14.0

-13.5

-10.0

-11.2

Total Plan Other Expense

22.7

21.2

18.3

17.0

15.8

 

 

Annual Balance Sheet

 

Financials in: USD (mil)

 

 

 

31-Mar-2013

31-Mar-2012

31-Mar-2011

31-Mar-2010

31-Mar-2009

UpdateType/Date

Updated Normal
31-Mar-2013

Updated Normal
31-Mar-2012

Updated Normal
31-Mar-2011

Updated Normal
31-Mar-2010

Updated Normal
31-Mar-2009

Filed Currency

JPY

JPY

JPY

JPY

JPY

Exchange Rate

94.088557

82.385362

82.88

93.44

98.77

Auditor

KPMG AZSA LLC

KPMG AZSA LLC

KPMG LLP

KPMG LLP

KPMG LLP

Auditor Opinion

Unqualified with Explanation

Unqualified with Explanation

Unqualified

Unqualified with Explanation

Unqualified with Explanation

 

 

 

 

 

 

    Cash & Equivalents

282.7

116.6

265.6

108.2

100.8

Cash and Short Term Investments

282.7

116.6

265.6

108.2

100.8

        Accounts Receivable - Trade, Gross

792.8

916.9

876.5

780.5

617.4

        Provision for Doubtful Accounts

-2.1

-2.4

-3.8

-5.9

-6.3

    Trade Accounts Receivable - Net

790.7

914.6

872.7

774.6

611.0

Total Receivables, Net

790.7

914.6

872.7

774.6

611.0

    Inventories - Finished Goods

457.8

582.2

468.1

412.4

495.8

    Inventories - Work In Progress

150.7

180.0

166.5

131.8

134.1

    Inventories - Raw Materials

146.2

179.4

161.6

124.8

137.5

Total Inventory

754.7

941.6

796.2

669.0

767.4

    Deferred Income Tax - Current Asset

66.9

89.5

38.6

31.8

42.1

    Other Current Assets

68.4

95.1

102.1

100.1

101.0

Other Current Assets, Total

135.3

184.6

140.8

131.9

143.0

Total Current Assets

1,963.5

2,157.4

2,075.3

1,683.7

1,622.3

 

 

 

 

 

 

        Land/Improvements

1,128.7

1,294.3

1,290.4

1,148.3

1,089.0

        Construction in Progress

98.9

65.9

43.8

41.3

49.8

        Other Property/Plant/Equipment

70.7

29.8

30.2

28.3

30.0

    Property/Plant/Equipment - Gross

1,298.3

1,389.9

1,364.4

1,217.9

1,168.7

Property/Plant/Equipment - Net

2,149.8

2,425.1

2,458.4

2,250.1

2,190.5

Goodwill, Net

-

5.5

7.6

5.0

3.9

Intangibles, Net

13.2

14.0

14.9

12.2

16.4

    LT Investment - Affiliate Companies

111.4

97.9

175.7

-

-

    LT Investments - Other

183.9

200.2

190.0

275.7

241.7

Long Term Investments

295.3

298.1

365.7

275.7

241.7

Note Receivable - Long Term

-

-

-

-

0.0

    Deferred Income Tax - Long Term Asset

176.8

228.5

323.5

286.1

273.6

    Other Long Term Assets

157.0

186.0

105.8

179.4

144.9

Other Long Term Assets, Total

333.8

414.6

429.3

465.5

418.5

Total Assets

4,755.6

5,314.5

5,351.3

4,692.2

4,493.4

 

 

 

 

 

 

Accounts Payable

515.0

579.5

592.0

485.4

375.3

Accrued Expenses

42.8

99.0

105.2

73.5

70.1

Notes Payable/Short Term Debt

544.3

624.3

601.7

583.6

576.9

Current Portion - Long Term Debt/Capital Leases

338.1

341.5

346.1

342.2

260.6

    Security Deposits

132.7

161.5

162.9

133.9

153.5

    Income Taxes Payable

-

12.6

13.7

7.1

6.1

    Deferred Income Tax - Current Liability

-

0.1

0.2

0.9

0.6

    Other Current Liabilities

178.9

158.3

150.1

123.8

126.8

Other Current liabilities, Total

311.7

332.5

326.9

265.7

287.0

Total Current Liabilities

1,751.9

1,976.7

1,972.0

1,750.4

1,570.1

 

 

 

 

 

 

    Long Term Debt

768.2

847.6

820.3

840.2

967.6

    Capital Lease Obligations

-

47.6

63.4

66.1

6.1

Total Long Term Debt

768.2

895.3

883.8

906.3

973.7

Total Debt

1,650.6

1,861.0

1,831.6

1,832.1

1,811.3

 

 

 

 

 

 

    Deferred Income Tax - LT Liability

262.3

334.6

374.7

335.0

356.7

Deferred Income Tax

262.3

334.6

374.7

335.0

356.7

Minority Interest

186.0

208.2

289.6

256.9

361.6

    Reserves

18.8

23.4

13.1

11.7

0.0

    Pension Benefits - Underfunded

190.8

215.4

196.7

168.4

155.0

    Other Long Term Liabilities

110.6

76.0

103.9

117.5

81.6

Other Liabilities, Total

320.3

314.8

313.7

297.6

236.6

Total Liabilities

3,288.6

3,729.7

3,833.8

3,546.1

3,498.7

 

 

 

 

 

 

    Common Stock

549.8

627.9

624.2

463.8

438.8

Common Stock

549.8

627.9

624.2

463.8

438.8

Additional Paid-In Capital

342.6

391.2

388.8

255.1

162.3

Retained Earnings (Accumulated Deficit)

229.2

206.9

186.8

148.6

137.4

Treasury Stock - Common

-3.1

-6.8

-6.8

-6.0

-2.7

Unrealized Gain (Loss)

470.2

515.3

463.8

402.5

381.5

    Translation Adjustment

-121.0

-148.1

-137.4

-116.0

-120.9

    Other Equity

0.0

0.0

-

-

-

    Other Comprehensive Income

-0.8

-1.4

-1.9

-1.9

-1.6

Other Equity, Total

-121.7

-149.5

-139.3

-117.9

-122.5

Total Equity

1,467.0

1,584.9

1,517.5

1,146.1

994.8

 

 

 

 

 

 

Total Liabilities & Shareholders’ Equity

4,755.6

5,314.5

5,351.3

4,692.2

4,493.4

 

 

 

 

 

 

    Shares Outstanding - Common Stock Primary Issue

888.4

886.7

886.7

746.7

697.9

Total Common Shares Outstanding

888.4

886.7

886.7

746.7

697.9

Treasury Shares - Common Stock Primary Issue

2.0

3.8

3.8

3.8

1.1

Employees

10,566

10,479

10,178

10,398

11,181

Number of Common Shareholders

86,736

83,747

85,883

85,220

83,488

Total Long Term Debt, Supplemental

1,106.3

1,189.1

1,170.7

1,165.9

1,226.5

Long Term Debt Maturing within 1 Year

338.1

341.5

339.3

328.1

258.9

Long Term Debt Maturing in Year 2

298.8

359.4

257.3

257.6

235.3

Long Term Debt Maturing in Year 3

226.9

353.3

287.0

227.5

389.0

Long Term Debt Maturing in Year 4

63.0

48.3

169.0

241.8

70.2

Long Term Debt Maturing in Year 5

165.2

62.0

83.7

32.3

200.7

Long Term Debt Maturing in 2-3 Years

525.7

712.7

544.3

485.0

624.3

Long Term Debt Maturing in 4-5 Years

228.2

110.3

252.7

274.0

270.9

Long Term Debt Matur. in Year 6 & Beyond

14.3

24.7

34.5

78.8

72.4

Total Capital Leases, Supplemental

43.8

77.8

81.2

80.2

7.8

Capital Lease Payments Due in Year 1

16.7

30.2

17.7

14.1

1.7

Capital Lease Payments Due in Year 2

19.9

18.5

18.1

14.4

1.8

Capital Lease Payments Due in Year 3

2.9

22.2

17.7

14.8

1.7

Capital Lease Payments Due in Year 4

1.8

2.8

21.4

14.5

1.7

Capital Lease Payments Due in Year 5

1.4

1.6

2.2

17.7

1.0

Capital Lease Payments Due in 2-3 Years

22.8

40.7

35.8

29.2

3.5

Capital Lease Payments Due in 4-5 Years

3.2

4.4

23.7

32.2

2.6

Cap. Lease Pymts. Due in Year 6 & Beyond

1.1

2.6

3.9

4.7

-

Pension Obligation - Domestic

638.4

751.5

758.7

627.5

616.2

Plan Assets - Domestic

424.5

413.0

396.6

367.6

285.8

Funded Status - Domestic

-213.9

-338.4

-362.1

-259.9

-330.4

Total Funded Status

-213.9

-338.4

-362.1

-259.9

-330.4

Discount Rate - Domestic

2.00%

2.00%

2.00%

2.00%

2.00%

Expected Rate of Return - Domestic

3.50%

3.50%

3.50%

2.50%

2.50%

Prepaid Benefits - Domestic

103.2

114.1

115.2

96.0

67.8

Accrued Liabilities - Domestic

-186.8

-210.0

-191.4

-163.2

-141.1

Other Assets, Net - Domestic

130.3

242.5

285.8

192.7

257.1

Net Assets Recognized on Balance Sheet

46.8

146.6

209.6

125.6

183.8

Total Plan Obligations

638.4

751.5

758.7

627.5

616.2

Total Plan Assets

424.5

413.0

396.6

367.6

285.8

 

 

Annual Cash Flows

 

Financials in: USD (mil)

 

 

 

31-Mar-2013

31-Mar-2012

31-Mar-2011

31-Mar-2010

31-Mar-2009

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal
31-Mar-2013

Reclassified Normal
31-Mar-2013

Updated Normal
31-Mar-2011

Updated Normal
31-Mar-2010

Updated Normal
31-Mar-2009

Filed Currency

JPY

JPY

JPY

JPY

JPY

Exchange Rate (Period Average)

82.970472

78.961215

85.691434

92.941082

100.484331

Auditor

KPMG AZSA LLC

KPMG AZSA LLC

KPMG LLP

KPMG LLP

KPMG LLP

Auditor Opinion

Unqualified with Explanation

Unqualified with Explanation

Unqualified

Unqualified with Explanation

Unqualified with Explanation

 

 

 

 

 

 

Net Income/Starting Line

154.0

137.6

58.2

-2.7

-206.4

    Depreciation

159.6

246.6

223.0

219.7

211.0

Depreciation/Depletion

159.6

246.6

223.0

219.7

211.0

    Amortization of Acquisition Costs

-11.4

-12.7

-11.4

-10.2

-9.7

Amortization

-11.4

-12.7

-11.4

-10.2

-9.7

    Unusual Items

26.9

44.0

130.0

49.0

150.0

    Equity in Net Earnings (Loss)

-7.9

-7.7

-2.9

2.0

14.7

    Other Non-Cash Items

18.4

29.9

22.9

18.0

-39.3

Non-Cash Items

37.4

66.2

150.0

69.1

125.4

    Accounts Receivable

20.6

-34.9

1.9

-127.0

214.0

    Inventories

74.8

-149.3

-54.0

142.6

56.0

    Prepaid Expenses

-3.7

1.8

-6.7

-24.5

-32.6

    Accounts Payable

-3.3

-23.6

42.8

93.5

-279.4

    Other Operating Cash Flow

-58.1

-50.1

-10.5

-48.2

-83.5

Changes in Working Capital

30.2

-256.0

-26.4

36.4

-125.5

Cash from Operating Activities

369.9

181.6

393.4

312.3

-5.1

 

 

 

 

 

 

    Purchase of Fixed Assets

-198.6

-211.0

-164.0

-155.2

-217.4

Capital Expenditures

-198.6

-211.0

-164.0

-155.2

-217.4

    Acquisition of Business

-

-

-

-

0.0

    Sale of Business

-

-

0.0

3.6

0.0

    Sale of Fixed Assets

7.5

7.8

11.5

18.9

70.6

    Sale/Maturity of Investment

67.4

6.3

1.5

3.5

11.2

    Purchase of Investments

-21.2

-1.5

-0.5

-11.3

-28.0

    Other Investing Cash Flow

8.8

7.7

16.4

-4.2

6.3

Other Investing Cash Flow Items, Total

62.4

20.2

28.9

10.5

60.1

Cash from Investing Activities

-136.1

-190.7

-135.1

-144.8

-157.3

 

 

 

 

 

 

    Other Financing Cash Flow

-30.1

-131.2

-40.0

-39.3

-31.1

Financing Cash Flow Items

-30.1

-131.2

-40.0

-39.3

-31.1

    Cash Dividends Paid - Common

-37.3

-39.2

-30.4

-26.3

-34.7

Total Cash Dividends Paid

-37.3

-39.2

-30.4

-26.3

-34.7

        Sale/Issuance of Common

3.5

0.1

193.7

2.5

0.1

        Repurchase/Retirement of Common

0.0

0.0

-0.1

-0.1

-0.2

    Common Stock, Net

3.4

0.0

193.7

2.4

-0.1

Issuance (Retirement) of Stock, Net

3.4

0.0

193.7

2.4

-0.1

    Short Term Debt, Net

-7.7

19.9

-53.0

-28.6

-54.8

        Long Term Debt Issued

425.3

381.2

197.6

445.3

683.6

        Long Term Debt Reduction

-385.4

-376.8

-383.6

-523.9

-389.9

    Long Term Debt, Net

39.9

4.4

-186.0

-78.6

293.8

Issuance (Retirement) of Debt, Net

32.2

24.3

-239.0

-107.2

238.9

Cash from Financing Activities

-31.8

-146.0

-115.7

-170.3

172.9

 

 

 

 

 

 

Foreign Exchange Effects

2.7

-2.5

-2.9

5.2

-10.0

Net Change in Cash

204.7

-157.6

139.7

2.4

0.5

 

 

 

 

 

 

Net Cash - Beginning Balance

114.3

277.7

116.1

104.7

97.0

Net Cash - Ending Balance

319.0

120.1

255.9

107.1

97.5

Cash Interest Paid

22.9

27.4

29.6

29.2

28.9

Cash Taxes Paid

14.0

16.0

3.2

12.8

63.8

 

 

Annual Income Statement

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           

 

 

31-Mar-2013

31-Mar-2012

31-Mar-2011

31-Mar-2010

31-Mar-2009

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal
31-Mar-2013

Updated Normal
31-Mar-2012

Updated Normal
31-Mar-2011

Updated Normal
31-Mar-2010

Updated Normal
31-Mar-2009

Filed Currency

JPY

JPY

JPY

JPY

JPY

Exchange Rate (Period Average)

82.970472

78.961215

85.691434

92.941082

100.484331

Auditor

KPMG AZSA LLC

KPMG AZSA LLC

KPMG LLP

KPMG LLP

KPMG LLP

Auditor Opinion

Unqualified with Explanation

Unqualified with Explanation

Unqualified

Unqualified with Explanation

Unqualified with Explanation

 

 

 

 

 

 

    Net Sales

4,085.9

4,426.3

3,974.4

3,429.8

3,655.0

Total Revenue

4,085.9

4,426.3

3,974.4

3,429.8

3,655.0

 

 

 

 

 

 

    Rounding adjustment Income Statement

-

0.0

-

-

-

    Cost Of Sales

3,226.4

3,480.2

3,092.3

2,729.6

2,944.5

    Other Selling/General/Admin. Expense

211.0

222.6

-

-

-

    Delivery & warehousing expenses

121.0

130.4

106.6

93.4

96.3

    Payrolls & bonuses

168.6

183.6

173.2

152.0

159.4

    Reserve for bonuses

16.4

18.6

17.6

13.0

14.7

    Periodic retirement benefit costs

18.2

23.8

17.9

19.2

14.2

    Research & Develop.expense

118.4

135.3

122.5

109.9

105.1

    Other SGA

-

-

200.4

189.3

209.1

    Other

-3.0

-

-

-

-

    Other

10.1

7.5

-

-

-

    SP Reversal G on allow.doubt.accounts

-

0.0

-0.2

-0.4

-0.4

    SP G Creation Trust Retirement Benefits

-

-

-

-

0.0

    SP G Retire. Plan Termination

-

-

-

-

0.0

    SP Condemnation Proceeds

-

-

-

-

0.0

    SP Subsidy income

-

-

-

0.0

-1.6

    SP Impairment loss

20.1

0.0

4.5

3.4

5.8

    SP L on the val of LT inv't in secs

-

-

52.5

5.1

15.2

    SP Provision for doubtful accounts

-

0.0

0.3

0.3

18.4

    SP Extra retirement payments

-

-

6.9

3.4

0.0

    SP L on Termination of Retire. Plan

-

0.0

0.4

0.9

8.5

    SP Environmental expenses

-

-

22.5

10.3

0.0

    SP Prov. for environmental measure

0.0

11.3

0.0

11.7

0.0

    SP L on adj. for changes of acct. asset

-

0.0

3.2

0.0

-

    SP Litigation Cost

16.1

28.3

28.3

22.2

16.7

    SP L on deduction fixed assets

-

-

-

0.0

1.5

    SP L on val. of inv't in closely-held

-

-

-

0.0

0.8

    SP Loss on bad debts

-

-

-

-

0.0

    SP Restructure Cost

-

-

-

0.0

117.3

    SP L on val inventories

-

-

-

0.0

40.4

    NOP Amortization of goodwill

-11.4

-12.7

-11.4

-10.2

-9.7

Total Operating Expense

3,911.9

4,228.9

3,837.7

3,353.2

3,756.2

 

 

 

 

 

 

    NOP Interest Income

-

2.6

2.7

3.2

3.7

    Foreign exchange gains

11.5

-

-

-

-

    Equity In Earnings Of Affiliates

7.9

7.7

-

-

-

    NOP Dividend income

10.4

9.6

8.3

7.9

7.6

    Other Non-Operating Income (Expense)

0.0

-

-

-

-

    Rounding adjustment Income Statement

-

0.0

-

-

-

    NOP Rental Income

-

-

5.5

6.5

8.9

    NOP Equity in Earnings

-

-

2.9

-

-

    NOP Facility install fees received

-

-

-

-

0.0

    NOP Other non-operating income

16.9

24.3

17.4

23.7

24.2

    NOP Interest Expenses

-22.8

-26.1

-29.4

-30.2

-30.8

    NOP Acct. Change/Pension

-18.9

-19.9

-18.3

-17.0

-15.7

    NOP Costs for loan employees

-8.4

-

0.0

-13.4

0.0

    NOP Equity losses

-

-

-

-2.0

-14.7

    NOP Other non-operating expenses

-26.7

-43.6

-45.5

-32.3

-84.2

    SP G on the sale of fixed assets

-

2.7

4.2

2.1

37.8

    SP G on the sale of LT inv't in secs

29.2

1.8

0.3

1.5

1.9

    Gain on sales of investments in capital

-

0.0

0.3

0.0

-

    SP Dividend Income

-

-

-

-

0.0

    SP L on the sale of fixed assets

-

-

-4.0

-2.1

-6.7

    SP L on the disposal of fixed assets

-19.1

-19.1

-14.9

-18.1

-17.5

    SP L on the sale of LT inv't in secs

-

0.0

-0.3

-0.8

-8.3

    SP L on Affiliates Liquidate

-

0.0

-0.3

-7.6

-11.5

    SP Loss on business transfer

-

0.0

-7.4

-0.8

0.0

Net Income Before Taxes

154.0

137.6

58.3

-2.7

-206.4

 

 

 

 

 

 

Provision for Income Taxes

53.0

65.1

-1.1

-28.1

-61.8

Net Income After Taxes

101.0

72.5

59.3

25.4

-144.6

 

 

 

 

 

 

    Minority interests in income

-8.9

-14.4

-10.8

-2.8

20.2

Net Income Before Extra. Items

92.1

58.1

48.5

22.5

-124.4

Net Income

92.1

58.1

48.5

22.5

-124.4

 

 

 

 

 

 

    Miscellaneous Earnings Adjustment

0.0

-

-

-

-

    Adjustment

-

-

0.0

0.0

0.0

Income Available to Com Excl ExtraOrd

92.1

58.1

48.5

22.5

-124.4

 

 

 

 

 

 

Income Available to Com Incl ExtraOrd

92.1

58.1

48.5

22.5

-124.4

 

 

 

 

 

 

Basic Weighted Average Shares

887.0

886.7

757.4

726.4

697.9

Basic EPS Excluding ExtraOrdinary Items

0.10

0.07

0.06

0.03

-0.18

Basic EPS Including ExtraOrdinary Items

0.10

0.07

0.06

0.03

-0.18

Dilution Adjustment

-

0.0

0.0

0.0

0.0

Diluted Net Income

92.1

58.1

48.5

22.5

-124.4

Diluted Weighted Average Shares

887.0

886.7

757.9

766.7

697.9

Diluted EPS Excluding ExtraOrd Items

0.10

0.07

0.06

0.03

-0.18

Diluted EPS Including ExtraOrd Items

0.10

0.07

0.06

0.03

-0.18

DPS-Ordinary Shares

0.04

0.04

0.04

0.04

0.03

Gross Dividends - Common Stock

37.5

39.4

36.3

28.2

24.3

Normalized Income Before Taxes

204.9

188.3

187.5

63.0

-47.5

 

 

 

 

 

 

Inc Tax Ex Impact of Sp Items

74.5

95.2

48.2

-1.5

-2.7

Normalized Income After Taxes

130.4

93.2

139.3

64.6

-44.7

 

 

 

 

 

 

Normalized Inc. Avail to Com.

121.5

78.8

128.5

61.7

-24.5

 

 

 

 

 

 

Basic Normalized EPS

0.14

0.09

0.17

0.08

-0.04

Diluted Normalized EPS

0.14

0.09

0.17

0.08

-0.04

Interest Expense

22.8

26.1

29.4

30.2

30.8

Amort. of Negative Goodwill

-11.4

-12.7

-11.4

-10.2

-9.7

Research and Development Expenses COGS

1.7

-

-

-

-

Total Search And Development Expense

-

1.7

-

-

-

Research and Development Expenses

118.4

135.3

-

-

-

R & D (SGA)

-

-

122.5

109.9

105.1

R & D (Cost of sales)

-

-

1.6

0.9

1.1

BC - Depreciation of Fixed Assets

159.6

-

-

-

-

Amort of Tangible Assets-Current Portion

-

246.6

-

-

-

Depreciation

-

-

223.0

219.7

211.0

    Income taxes-current

28.8

20.5

-

-

-

Current Tax - Total

28.8

20.5

-

-

-

    Income taxes-deferred

24.2

44.6

-

-

-

Deferred Tax - Total

24.2

44.6

-

-

-

Income Tax - Total

53.0

65.1

-

-

-

Reported Operating Profit

205.9

231.8

243.8

123.4

111.7

Reported Ordinary Profit

187.1

199.2

198.9

80.1

20.5

Service cost

27.8

27.6

25.5

25.7

24.5

Interest cost

13.7

14.5

15.2

14.4

13.4

Expected return on plan assets

-13.9

-14.0

-13.5

-10.0

-11.2

Pension exp. due to acct. changes

18.9

19.9

18.3

17.0

15.8

Actuarial gains and losses

21.7

32.1

26.6

27.8

16.2

Prior service cost

0.9

1.0

-3.2

-3.6

-3.3

Transit. G to Defined Contribution Plan

-

-

-

-

0.0

Retirement Benefit Expenses Other Extrao

3.8

1.3

-

-

-

Domestic Pension Plan Expense

72.9

82.4

68.9

71.3

55.3

Defined Contribution Expense

-

1.3

0.7

0.7

0.7

Total Pension Expense

72.9

83.7

69.6

71.9

56.0

Discount Rate - Domestic

2.00%

2.00%

-

-

-

Discount rate

-

-

2.00%

2.00%

2.00%

Expected Rate of Return - Domestic

3.50%

3.50%

-

-

-

Plan asset expected rate of return

-

-

3.50%

2.50%

2.50%

 

 

Annual Balance Sheet

 

Financials in: USD (mil)

 

 

 

31-Mar-2013

31-Mar-2012

31-Mar-2011

31-Mar-2010

31-Mar-2009

UpdateType/Date

Updated Normal
31-Mar-2013

Updated Normal
31-Mar-2012

Updated Normal
31-Mar-2011

Updated Normal
31-Mar-2010

Updated Normal
31-Mar-2009

Filed Currency

JPY

JPY

JPY

JPY

JPY

Exchange Rate

94.088557

82.385362

82.88

93.44

98.77

Auditor

KPMG AZSA LLC

KPMG AZSA LLC

KPMG LLP

KPMG LLP

KPMG LLP

Auditor Opinion

Unqualified with Explanation

Unqualified with Explanation

Unqualified

Unqualified with Explanation

Unqualified with Explanation

 

 

 

 

 

 

    Cash & deposits

282.7

116.6

265.6

108.2

100.8

    Notes and accounts receivable-trade

792.8

916.9

876.5

780.5

617.4

    Inventories - merch. & fini. Goods

457.8

582.2

468.1

412.4

495.8

    Inventories - work-in-process

150.7

180.0

166.5

131.8

134.1

    Inventories - raw mate. & supp.

146.2

179.4

161.6

124.8

137.5

    Deferred income taxes (current)

66.9

89.5

38.6

31.8

42.1

    Rounding adjustment Assets

0.0

0.0

-

-

-

    Other current assets

68.4

95.1

102.1

100.1

101.0

    Allow.doubt.accounts (current)

-2.1

-2.4

-3.8

-5.9

-6.3

Total Current Assets

1,963.5

2,157.4

2,075.3

1,683.7

1,622.3

 

 

 

 

 

 

    Buildings and structures, net

491.4

564.8

573.2

523.0

477.9

    Machinery Equipment And Vehicles

360.0

410.0

446.7

434.2

542.1

    Land

1,128.7

1,294.3

1,290.4

1,148.3

1,089.0

    Lease assets, net

-

60.3

74.0

75.0

1.7

    Construction-in-progress

98.9

65.9

43.8

41.3

49.8

    Other

70.7

29.8

30.2

28.3

30.0

    Goodwill

-

5.5

7.6

5.0

3.9

    Other intangible assets

13.2

14.0

14.9

12.2

16.4

    Investment Securities - Balancing value

183.9

-

-

-

-

    Pth LT Inv

-

200.2

-

-

-

    Long-term investment in securities

-

-

190.0

275.7

241.7

    Invt Secs Noncons, Asc, Affd Cos

102.4

88.2

-

-

-

    Invts in Capital Noncons, Ascd, Affd Cos

9.0

9.7

-

-

-

    Equity secs.-nonconsolidated affil.

-

-

85.2

-

-

    LT Loans

-

-

-

-

0.0

    Deferred tax assets

176.8

228.5

323.5

286.1

273.6

    Other - Balancing value

170.0

-

-

-

-

    Other Long Term Assets

0.0

-

-

-

-

    Rounding adjustment Assets

-

0.0

-

-

-

    Other Other Long Term Assets

-

203.0

-

-

-

    Other Assets

-

-

123.3

195.9

187.4

    Other-secs.nonconsolid.affiliates

-

-

85.2

-

-

    Inv't partnership-nonconsol.affil.

-

-

5.4

-

-

    Allow.doubt.accounts (non-current)

-13.0

-17.0

-17.5

-16.5

-42.5

    Adjustment

-

-

-

0.0

0.0

Total Assets

4,755.6

5,314.5

5,351.3

4,692.2

4,493.4

 

 

 

 

 

 

    Notes and accounts payable-trade

515.0

579.5

592.0

485.4

375.3

    Short-term loans payable

544.3

624.3

601.7

583.6

576.9

    Current Portion Of Bonds

106.3

-

-

-

-

    Current portion of long-term loans payab

231.9

341.5

325.7

328.1

258.9

    Straight bonds (current)

-

-

2.7

-

0.0

    Lease Obligation

-

-

17.7

14.1

1.7

    Accrued expenses

-

49.3

55.5

33.6

30.8

    Income taxes payable

-

12.6

13.7

7.1

6.1

    Deferred tax liabilities (current)

-

0.1

0.2

0.9

0.6

    Deposits received

132.7

161.5

162.9

133.9

153.5

    Reserve for bonuses

42.8

49.6

49.7

39.9

39.3

    Other current liabilities

178.9

158.3

150.1

123.8

126.8

Total Current Liabilities

1,751.9

1,976.7

1,972.0

1,750.4

1,570.1

 

 

 

 

 

 

    Straight bonds

212.6

182.1

181.0

162.9

151.9

    Bond with stock purchase warrants

-

-

-

2.4

202.5

    Long-term loans payable

555.6

665.6

639.4

674.9

613.3

    Lease obligations

-

47.6

63.4

66.1

6.1

Total Long Term Debt

768.2

895.3

883.8

906.3

973.7

 

 

 

 

 

 

    Deferred tax liabilities (non-current)

-

35.2

35.0

33.1

71.0

    Deferred tax liabilities revaluation

262.3

299.5

339.7

301.8

285.7

    Reserve for retirement benefits

186.8

210.0

191.4

163.2

141.1

    Provision for directors'' retirement ben

4.0

5.4

5.2

5.2

13.9

    Other Long Term Liabilities

0.0

0.0

-

-

-

    Negative goodwill

-

26.8

38.4

44.6

9.3

    Reserve for environmental measures

18.8

23.4

13.1

11.7

0.0

    Other Long-term liabilities

110.6

49.3

65.5

72.9

72.3

    Minority interests

186.0

208.2

289.6

256.9

361.6

Total Liabilities

3,288.6

3,729.7

3,833.8

3,546.1

3,498.7

 

 

 

 

 

 

    Rounding adjustment Equity

0.0

-

-

-

-

    Rounding adjustment Equity

-

0.0

-

-

-

    Common Stock

549.8

627.9

624.2

463.8

438.8

    Total capital surpluses

342.6

391.2

388.8

255.1

162.3

    Total retained earnings

229.2

206.9

186.8

148.6

137.4

    Treasury Stock

-3.1

-6.8

-6.8

-6.0

-2.7

    Valuation difference on available-for-sa

29.9

12.6

3.7

-6.3

-16.4

    Deferred hedge gain/loss

-0.8

-1.4

-1.9

-1.9

-1.6

    Revalue. Excess

440.2

502.7

460.1

408.8

397.9

    Revalue. Res.

-

-

-

-

0.0

    Translat. Adjust

-121.0

-148.1

-137.4

-116.0

-120.9

Total Equity

1,467.0

1,584.9

1,517.5

1,146.1

994.8

 

 

 

 

 

 

Total Liabilities & Shareholders' Equity

4,755.6

5,314.5

5,351.3

4,692.2

4,493.4

 

 

 

 

 

 

    S/O-Ordinary Shares

888.4

886.7

886.7

746.7

697.9

Total Common Shares Outstanding

888.4

886.7

886.7

746.7

697.9

T/S-Ordinary Shares

2.0

3.8

3.8

3.8

1.1

Total Number of Employee

10,566

10,479

-

-

-

Full-Time Employees

-

-

10,178

10,398

11,181

Total Number of Shareholders

86,736

83,747

-

-

-

Number of Common Shareholders

-

-

85,883

85,220

83,488

Bond Redemption Amounts within A Year

106.3

-

-

-

-

LT Debts Maturing within 1 Year

231.9

341.5

339.3

328.1

258.9

Bond Redemp Amts over a Yr within 2 Yrs

-

121.4

-

-

-

Lns Pble Maturing over a Yr within 2 Yrs

298.8

238.1

-

-

-

LT Debts Maturing within 2 Years

-

-

257.3

257.6

235.3

Lns Pble Maturg over 2 Yrs within 3 Yrs

120.6

292.6

-

-

-

LT Debts Maturing within 3 Years

-

-

287.0

227.5

389.0

Bond Redemp Amts over 2Yrs within 3Yrs

106.3

60.7

-

-

-

Lns Pble Maturg over 3 Yrs within 4 Yrs

63.0

48.3

-

-

-

LT Debts Maturing within 4 Years

-

-

169.0

241.8

70.2

Over Four Years And Within Five Years

106.3

-

-

-

-

Lns Pble Maturg over 4 Yrs within 5 Yrs

58.9

62.0

-

-

-

LT Debts Maturing within 5 Years

-

-

83.7

32.3

200.7

Oth LT Debt Remaining Mat

14.3

24.7

-

-

-

LT Debts Maturing after 5 years

-

-

34.5

78.8

72.4

Total Long Term Debt, Supplemental

1,106.3

1,189.1

1,170.7

1,165.9

1,226.5

Division And End Of Current Period Remai

-

11.2

-

-

-

Capital Lease Payments Due within 1 Year

16.7

19.0

17.7

14.1

1.7

Cap Lease Maturg over a Yr within 2 Yrs

19.9

18.5

-

-

-

Capital Lease Payments Due in Year 2

-

-

18.1

14.4

1.8

Cap Lease Maturg over 2 Yr within 3 Yrs

2.9

22.2

-

-

-

Capital Lease Payments Due in Year 3

-

-

17.7

14.8

1.7

Cap Lease Maturg over 3 Yr within 4 Yrs

1.8

2.8

-

-

-

Capital Lease Payments Due in Year 4

-

-

21.4

14.5

1.7

Cap Lease Maturg over 4 Yr within 5 Yrs

1.4

1.6

-

-

-

Capital Lease Payments Due in Year 5

-

-

2.2

17.7

1.0

Division And End Of Current Period Remai

-

0.0

-

-

-

Oth Lease Cap Remaining

1.1

2.6

-

-

-

Capital Leases - Remaining Maturities

-

-

3.9

4.7

-

Total Capital Leases, Supplemental

43.8

77.8

81.2

80.2

7.8

Pension obligation

638.4

751.5

758.7

627.5

616.2

Fair value of plan asset

359.4

342.5

333.0

303.3

232.4

Pension retirement trust

65.1

70.5

63.6

64.2

53.4

Funded status

-213.9

-338.4

-362.1

-259.9

-330.4

Total Funded Status

-213.9

-338.4

-362.1

-259.9

-330.4

Discount rate

2.00%

2.00%

2.00%

2.00%

2.00%

Expected rate of return

3.50%

3.50%

3.50%

2.50%

2.50%

Expense unrecog. for acc. Changes

33.5

57.3

75.9

84.1

95.8

Unrecognized actuarial gains and losses

90.4

176.9

200.7

111.6

167.4

Unrecognized prior service cost

6.5

8.3

9.2

-3.0

-6.2

Prepaid pension benefits

103.2

114.1

115.2

96.0

67.8

Accrued pension benefit

-186.8

-210.0

-191.4

-163.2

-141.1

Net Assets Recognized on Balance Sheet

46.8

146.6

209.6

125.6

183.8

 

spacebar

 

 

Annual Cash Flows

Financials in: USD (mil)

 

 

 

 

 

31-Mar-2013

31-Mar-2012

31-Mar-2011

31-Mar-2010

31-Mar-2009

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal
31-Mar-2013

Reclassified Normal
31-Mar-2013

Updated Normal
31-Mar-2011

Updated Normal
31-Mar-2010

Updated Normal
31-Mar-2009

Filed Currency

JPY

JPY

JPY

JPY

JPY

Exchange Rate (Period Average)

82.970472

78.961215

85.691434

92.941082

100.484331

Auditor

KPMG AZSA LLC

KPMG AZSA LLC

KPMG LLP

KPMG LLP

KPMG LLP

Auditor Opinion

Unqualified with Explanation

Unqualified with Explanation

Unqualified

Unqualified with Explanation

Unqualified with Explanation

 

 

 

 

 

 

Net Income Bf. Tax

154.0

137.6

58.2

-2.7

-206.4

    Depreciation

159.6

246.6

223.0

219.7

211.0

    Amortization of goodwill

-11.4

-12.7

-11.4

-10.2

-9.7

    Increase (decrease) in allowance for dou

-2.3

-1.8

-3.6

-27.4

-60.2

    Increase (decrease) in provision for env

-

-

-0.1

11.7

0.0

    Environmental expenses

-

-

22.5

0.0

-

    Increase (decrease) in provision for ret

9.9

17.9

8.1

14.6

2.7

    Int. & Divid. Income

-12.0

-12.3

-11.0

-11.1

-11.3

    Interest Expenses

22.8

26.1

29.4

30.2

30.8

    Equity in (earnings) losses of affiliate

-7.9

-7.7

-2.9

2.0

14.7

    Special Dividend

-

-

-

-

0.0

    Impairment loss

20.1

0.0

4.5

3.4

5.8

    L on deduct. of fixed assets

-

-

-

0.0

1.5

    Loss (gain) on sales and disposal of pro

17.3

16.8

14.7

18.2

-13.6

    Loss (gain) on sales and valuation of in

-26.5

-1.1

52.5

4.4

21.6

    L on val. of inv't in closely-held

-

-

-

0.0

0.8

    Restructure Cost

-

-

-

0.0

117.3

    Loss on transfer of business

-

-

7.4

0.8

0.0

    Compensation on relocation

-

-

-

-

0.0

    Litigation Cost

16.1

28.3

28.3

22.2

16.7

    Decrease (increase) in notes and account

20.6

-34.9

1.9

-127.0

214.0

    Decrease (increase) in inventories

74.8

-149.3

-54.0

142.6

56.0

    Increase (decrease) in notes and account

-3.3

-23.6

42.8

93.5

-279.4

    Decrease (increase) in prepaid pension c

-3.7

1.8

-6.7

-24.5

-32.6

    Other Non-classified Cash Flows Section

0.0

0.0

-

-

-

    Increase (decrease) in cash and cash equ

4.0

1.9

-

-

-

    Rounding adjustment Cash flow

0.0

0.0

-

-

-

    Other, net

-30.9

-2.0

14.2

-13.4

8.3

    Restruct. Cost Paid

-

-

-

0.0

-12.5

    Payments for loss on litigation

-17.2

-34.0

-21.5

-22.0

-15.5

    Litigation compensation insurance

-

-

-

-

0.0

    Insurance income from disaster

-

-

-

-

0.0

    Income taxes (paid) refund

-14.0

-16.0

-3.2

-12.8

-63.8

    Cash to change in consol. scope

-

-

-

-

-1.5

    Increase due to mergers

-

-

-

-

0.0

Cash from Operating Activities

369.9

181.6

393.4

312.3

-5.1

 

 

 

 

 

 

    Purchase Of Investments In Subsidiaries

-20.9

-0.9

-

-

-

    Proceeds from sales of investments in su

19.6

0.0

-

-

-

    Purchase of property, plant and equipmen

-198.6

-211.0

-164.0

-155.2

-

    Proceeds from sales of property, plant a

7.5

7.8

11.5

18.9

-

    Capital Expenditure/ Tangible asset

-

-

-

-

-217.4

    Sales of Tangible Asset

-

-

-

-

70.6

    Purch.Invest.in Secs

-0.4

-0.6

-0.5

-11.3

-28.0

    Sales of Inv. Secs.

47.0

4.1

1.3

3.1

7.9

    Proceeds from transfer of business

-

-

0.0

3.6

0.0

    Purchase of businesses

-

-

-

-

0.0

    Purchase of subs.' securities

-

-

-

-

0.0

    Inflow purchase of consol. subs.' secs.

-

-

-

-

0.0

    Rounding adjustment Cash flow

-

0.0

-

-

-

    Int & Divd. Received

11.6

12.4

11.2

11.1

11.7

    Divid. Paid-Eqity

0.7

2.2

0.2

0.4

3.3

    Other, net

-2.8

-4.7

5.2

-15.3

-5.3

Cash from Investing Activities

-136.1

-190.7

-135.1

-144.8

-157.3

 

 

 

 

 

 

    Net increase (decrease) in short-term lo

-7.7

19.9

-53.0

-28.6

-54.8

    Proceeds From Issuance Of Bonds

180.8

0.0

-

-

-

    Proceeds from long-term loans payable

244.5

381.2

197.6

372.3

315.0

    Repayment of long-term loans payable

-352.9

-345.5

-357.9

-291.2

-280.9

    Payment for retirement by preferred secu

0.0

-91.7

-

-

-

    Other, net(1)

0.0

-2.8

-

-

-

    Rounding adjustment Cash flow

0.0

0.0

-

-

-

    Preferred secs. extinguishment

-

-

0.0

-

-

    Preferred equity issue

-

-

-

0.0

215.3

    Bond with Stock Purchase Warrants

-

-

-

-

0.0

    Bond Redemption with Stock Pur. Warrants

-

-

0.0

-212.8

-

    Issuance of Bonds

-

-

-

0.0

148.3

    Redemption of Bonds

-

-

-

0.0

-99.5

    Proceeds from issuance of common stock

-

-

193.7

0.0

-

    Purch. Treasury Stock

0.0

0.0

-0.1

-0.1

-0.2

    Sale of Treasury

3.5

0.1

0.0

2.5

0.1

    Repayment of finance lease

-32.5

-31.3

-25.6

-20.0

-9.4

    Interest Paid

-22.9

-27.4

-29.6

-29.2

-28.9

    Dividends Paid

-37.3

-39.2

-30.4

-26.3

-34.7

    Divid. Paid-Minority

-7.2

-9.3

-10.5

-10.0

-2.3

    Other, net

-

-

0.0

-

-

    Proceed from sale and lease back

-

-

0.0

73.1

5.0

Cash from Financing Activities

-31.8

-146.0

-115.7

-170.3

172.9

 

 

 

 

 

 

Foreign Exchange Effects

2.7

-2.5

-2.9

5.2

-10.0

Net Change in Cash

204.7

-157.6

139.7

2.4

0.5

 

 

 

 

 

 

Net Cash - Beginning Balance

114.3

277.7

116.1

104.7

97.0

Net Cash - Ending Balance

319.0

120.1

255.9

107.1

97.5

    Cash Interest Paid

22.9

27.4

29.6

29.2

28.9

    Cash Taxes Paid

14.0

16.0

3.2

12.8

63.8

 

Financial Health

 

Financials in: USD (mil)                                                                

Except for share items (millions) and per share items (actual units)  

 

Key Indicators USD (mil)

 

Quarter
Ending
31-Mar-2013

Quarter
Ending
Yr Ago

Annual
Year End
31-Mar-2013

1 Year
Growth

3 Year
Growth

5 Year
Growth

Total Revenue1 (?)

975.2

-1.05%

4,085.9

-3.00%

2.07%

-4.71%

Research & Development1 (?)

-

-

118.4

-8.09%

-1.30%

-1.78%

Operating Income1 (?)

48.3

213.56%

174.0

-7.39%

26.55%

12.61%

Income Available to Common Excl Extraord Items1 (?)

34.0

-

92.1

66.54%

53.94%

10.21%

Basic EPS Excl Extraord Items1 (?)

0.04

-

0.10

66.48%

44.02%

5.05%

Capital Expenditures2 (?)

198.6

-

198.6

-1.10%

4.52%

-11.36%

Cash from Operating Activities2 (?)

369.9

-

369.9

113.99%

1.88%

5.41%

Free Cash Flow (?)

151.1

-

151.1

-

-0.88%

-

Total Assets3 (?)

4,755.6

2.19%

4,755.6

2.19%

0.68%

-1.98%

Total Liabilities3 (?)

3,288.6

0.70%

3,288.6

0.70%

-2.26%

-3.24%

Total Long Term Debt3 (?)

768.2

3.50%

768.2

-2.01%

-5.14%

-1.47%

Employees3 (?)

-

-

10566

0.83%

0.54%

-1.84%

Total Common Shares Outstanding3 (?)

888.4

0.20%

888.4

0.20%

5.97%

4.95%

1-ExchangeRate: JPY to USD Average for Period

92.002316

 

82.970472

 

 

 

2-ExchangeRate: JPY to USD Average for Period

82.970472

 

82.970472

 

 

 

3-ExchangeRate: JPY to USD Period End Date

94.088557

 

94.088557

 

 

 

Key Ratios

 

31-Mar-2013

31-Mar-2012

31-Mar-2011

31-Mar-2010

31-Mar-2009

Profitability

Gross Margin (?)

21.04%

21.37%

22.20%

20.42%

18.33%

Operating Margin (?)

4.26%

4.46%

3.44%

2.23%

-2.77%

Pretax Margin (?)

3.77%

3.11%

1.47%

-0.08%

-5.65%

Net Profit Margin (?)

2.25%

1.31%

1.22%

0.66%

-3.40%

Financial Strength

Current Ratio (?)

1.12

1.09

1.05

0.96

1.03

Long Term Debt/Equity (?)

0.52

0.56

0.58

0.79

0.98

Total Debt/Equity (?)

1.13

1.17

1.21

1.60

1.82

Management Effectiveness

Return on Assets (?)

1.89%

1.30%

1.15%

0.53%

-3.10%

Return on Equity (?)

5.69%

3.58%

3.57%

2.04%

-10.97%

Efficiency

Receivables Turnover (?)

4.53

4.73

4.71

4.80

5.11

Inventory Turnover (?)

3.60

3.83

4.12

3.67

3.70

Asset Turnover (?)

0.77

0.79

0.77

0.72

0.78

Market Valuation USD (mil)

P/E (TTM) (?)

19.05

.

Enterprise Value2 (?)

3,106.0

Price/Sales (TTM) (?)

0.43

.

Enterprise Value/Revenue (TTM) (?)

0.86

Price/Book (MRQ) (?)

1.06

.

Enterprise Value/EBITDA (TTM) (?)

9.64

Market Cap as of 19-Jul-20131 (?)

1,452.4

.

 

 

1-ExchangeRate: JPY to USD on 19-Jul-2013

100.547528

 

 

 

2-ExchangeRate: JPY to USD on 31-Mar-2013

94.088557

 

 

 

 

 

Annual Ratios

 

Financials in: USD (mil)                                                                

Except for share items (millions) and per share items (actual units)  

 

 

 

31-Mar-2013

31-Mar-2012

31-Mar-2011

31-Mar-2010

31-Mar-2009

Financial Strength

Current Ratio (?)

1.12

1.09

1.05

0.96

1.03

Quick/Acid Test Ratio (?)

0.61

0.52

0.58

0.50

0.45

Working Capital1 (?)

211.6

180.7

103.3

-66.6

52.2

Long Term Debt/Equity (?)

0.52

0.56

0.58

0.79

0.98

Total Debt/Equity (?)

1.13

1.17

1.21

1.60

1.82

Long Term Debt/Total Capital (?)

0.25

0.26

0.26

0.30

0.35

Total Debt/Total Capital (?)

0.53

0.54

0.55

0.62

0.65

Payout Ratio (?)

40.64%

67.65%

63.80%

121.41%

-19.53%

Effective Tax Rate (?)

34.43%

47.34%

-1.80%

-

-

Total Capital1 (?)

3,117.6

3,445.9

3,349.1

2,978.2

2,806.0

 

 

 

 

 

 

Efficiency

Asset Turnover (?)

0.77

0.79

0.77

0.72

0.78

Inventory Turnover (?)

3.60

3.83

4.12

3.67

3.70

Days In Inventory (?)

101.29

95.34

88.50

99.50

98.58

Receivables Turnover (?)

4.53

4.73

4.71

4.80

5.11

Days Receivables Outstanding (?)

80.61

77.11

77.55

75.99

71.44

Revenue/Employee2 (?)

341,007

404,840

403,737

328,094

332,568

Operating Income/Employee2 (?)

14,522

18,057

13,885

7,331

-9,205

EBITDA/Employee2 (?)

27,846

40,613

36,543

28,347

9,997

 

 

 

 

 

 

Profitability

Gross Margin (?)

21.04%

21.37%

22.20%

20.42%

18.33%

Operating Margin (?)

4.26%

4.46%

3.44%

2.23%

-2.77%

EBITDA Margin (?)

8.17%

10.03%

9.05%

8.64%

3.01%

EBIT Margin (?)

4.26%

4.46%

3.44%

2.23%

-2.77%

Pretax Margin (?)

3.77%

3.11%

1.47%

-0.08%

-5.65%

Net Profit Margin (?)

2.25%

1.31%

1.22%

0.66%

-3.40%

R&D Expense/Revenue (?)

2.90%

3.06%

3.08%

3.20%

2.88%

COGS/Revenue (?)

78.96%

78.63%

77.80%

79.58%

81.67%

SG&A Expense/Revenue (?)

13.10%

13.08%

12.98%

13.61%

13.51%

 

 

 

 

 

 

Management Effectiveness

Return on Assets (?)

1.89%

1.30%

1.15%

0.53%

-3.10%

Return on Equity (?)

5.69%

3.58%

3.57%

2.04%

-10.97%

 

 

 

 

 

 

Valuation

Free Cash Flow/Share2 (?)

0.17

-0.03

0.27

0.21

-0.32

Operating Cash Flow/Share 2 (?)

0.37

0.20

0.46

0.42

-0.01

1-ExchangeRate: JPY to USD Period End Date

94.088557

82.385362

82.88

93.44

98.77

2-ExchangeRate: JPY to USD Average for Period

94.088557

82.385362

82.88

93.44

98.77

 

Current Market Multiples

Market Cap/Earnings (TTM) (?)

19.09

Market Cap/Equity (MRQ) (?)

1.06

Market Cap/Revenue (TTM) (?)

0.43

Market Cap/EBIT (TTM) (?)

8.10

Market Cap/EBITDA (TTM) (?)

4.81

Enterprise Value/Earnings (TTM) (?)

38.20

Enterprise Value/Equity (MRQ) (?)

2.12

Enterprise Value/Revenue (TTM) (?)

0.86

Enterprise Value/EBIT (TTM) (?)

16.21

Enterprise Value/EBITDA (TTM) (?)

9.62

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.39

UK Pound

1

Rs.94.17

Euro

1

Rs.81.70

 

 

INFORMATION DETAILS

 

Report Prepared by :

SDA

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)